Search Result

Results for "

Antigen

" in MedChemExpress (MCE) Product Catalog:

By Targets:	HuR (6) PSMA (15) 5-HT Receptor (4) ADC Antibody (4) ADC Linker (6) Akt (1) Amino Acid Derivatives (1) Androgen Receptor (3) Angiotensin Receptor (2) Antibiotic (3) Antibody-Drug Conjugates (ADCs) (2) Apoptosis (12) Arenavirus (2) Arginase (1) Autophagy (1) Bacterial (16) Bcl-2 Family (1) Biochemical Assay Reagents (39) Btk (4) Calmodulin (1) Cannabinoid Receptor (1) Carbonic Anhydrase (2) Caspase (3) Cathepsin (2) CD19 (6) CD20 (3) CD22 (2) CD28 (1) CD3 (5) CDK (4) Cholecystokinin Receptor (1) CMV (1) COX (1) CTLA-4 (4) Cytochrome P450 (2) DNA/RNA Synthesis (5) DOCK (1) Drug-Linker Conjugates for ADC (4) EBV (17) Elastase (1) Endogenous Metabolite (27) Epigenetic Reader Domain (1) ERK (1) Factor Xa (2) FAK (1) Ferroptosis (3) Fluorescent Dye (17) Fungal (3) Furin (2) GABA Receptor (1) Galectin (1) Glucocorticoid Receptor (1) Glycosyltransferase (1) HBV (22) HCV (3) HDAC (2) Histamine Receptor (4) HIV (7) HIV Protease (3) HPV (2) HSP (1) HSV (5) IFNAR (2) Influenza Virus (4) Integrin (15) Interleukin Related (9) Isotope-Labeled Compounds (18) JAK (2) Keap1-Nrf2 (3) Lactate Dehydrogenase (1) LAG-3 (1) Leukotriene Receptor (6) Ligands for E3 Ligase (1) Liposome (8) Lipoxygenase (2) LPL Receptor (3) mAChR (1) MDM-2/p53 (2) Mesothelin (1) MMP (1) Molecular Glues (1) Mucin (1) nAChR (2) Necroptosis (2) NF-κB (3) NO Synthase (2) NOD-like Receptor (NLR) (1) Nuclear Factor of activated T Cells (NFAT) (1) p38 MAPK (1) Parasite (13) PARP (2) PD-1/PD-L1 (1) PDK-1 (1) Phosphatase (5) Phosphodiesterase (PDE) (4) Phospholipase (5) Platelet-activating Factor Receptor (PAFR) (1) Prostaglandin Receptor (3) PROTAC Linkers (1) Proteasome (2) RABV (2) Radionuclide-Drug Conjugates (RDCs) (3) RANKL/RANK (1) Reactive Oxygen Species (5) ROS Kinase (3) Ser/Thr Protease (1) SHP2 (3) Sirtuin (1) Small Interfering RNA (siRNA) (1) STAT (5) STING (3) Syk (6) Tim3 (1) TNF Receptor (6) Toll-like Receptor (TLR) (22) Topoisomerase (1) Transmembrane Glycoprotein (1) TROP2 (3) Tyrosinase (1) β-catenin (2)
By Research Areas:	Cancer (190) Cardiovascular Disease (9) Endocrinology (2) Infection (79) Inflammation/Immunology (228) Metabolic Disease (19) Neurological Disease (11)
Click Chemistry:	Azide (1)
Oligonucleotides:	Aptamers (1) Phospholipids (1) mRNA (3) Adjuvant (18) Cationic Lipids (3) Polymers (6) siRNAs (1)

430

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

105

Peptides

MCE Kits

Inhibitory Antibodies

Natural
Products

758

Recombinant Proteins

Isotope-Labeled Compounds

205

Antibodies

Click Chemistry

Oligonucleotides

4-[3-(Trifluoromethyl)diazirin-3-yl] benzoic acid N-hydroxysuccinimide ester	Biochemical Assay Reagents	Others
4-[3-(Trifluoromethyl)diazirin-3-yl] benzoic acid N-hydroxysuccinimide ester is a photoactivated bifunctional cross-linker. 4-[3-(Trifluoromethyl)diazirin-3-yl] benzoic acid N-hydroxysuccinimide ester can be used for researching a strategy of rapid and accurate structure generation in support of antigen engineering programs .

Clivatuzumab	Mucin	Cancer
Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers .

*Blood group A antigen* tetraose type 5** A-Tetrasaccharide	Others	Others
Blood group A antigen tetraose type 5 (A-Tetrasaccharide) is a tetrasaccharide and a blood group specific oligosaccharide, inhibits the binding of anti-A antibody to blood group A substance. Blood group A antigen tetraose type 5 can be isolated from polar bear milk samples .

AdCaPy	Others	Inflammation/Immunology
AdCaPy is an MHC II antigen loading catalyst that accelerates the loading of peptide antigens by MHC II. AdCaPy is a useful molecular tool for enhancing immune responses .

*Prostate Specific Antigen* Substrate**	PSMA	Cancer
Prostate Specific Antigen Substrate is a prostate specific antigen (PSA) fluorescent substrate. Prostate Specific Antigen Substrate can be used for detect enzymatic activity of PSA .

Dinotefuran-NHCO-propionic acid	Others	Inflammation/Immunology
Dinotefuran-NHCO-propionic acid (4) is an antigen. Dinotefuran-NHCO-propionic acid can couple BSA and OVA to obtain the immunogen and the coating antigen (hapten-OVA conjugate) .

*Prostate specific antigen* protein (human)** PSA; Native human prostate specific Antigen protein	Prostaglandin Receptor	Endocrinology
Prostate specific antigen protein (human) is a serine protease which produced by prostatic epithelium. Prostate specific antigen protein (human) can be used to study prostatic cancer .

VLVNTFCDSCIPKTYWNLGY TFA	mAChR	Neurological Disease
VLVNTFCDSCIPKTYWNLGY TFA is an antigenic peptide of M3 muscarinic receptor (M3R). VLVNTFCDSCIPKTYWNLGY TFA can be used in ELISA .

Diacylglyceride	Biochemical Assay Reagents	Inflammation/Immunology
Diacylglyceride, a natural scaffolding lipid, is a hapten that binds to CD1b. Diacylglyceride can be combined with carrier proteins and used in the design of antigens .

Methylthiomcresol-C5-COOH	Others	Others
Methylthiomcresol-C5-COOH (Compound F4) is a hapten that can be conjugated to carrier proteins for antigen design. Methylthiomcresol-C5-COOH designed antigen can be applied in ELISA to detect the residual amount of fenthion in white wine samples .

Methylthiomcresol-C3-COOH	Others	Others
Methylthiomcresol-C3-COOH (Compound F2) is a hapten that can be conjugated to carrier proteins for antigen design. Methylthiomcresol-C3-COOH designed antigen can be applied in ELISA to detect the residual amount of fenthion in white wine samples .

Avidin, chiken egg white	Biochemical Assay Reagents	Inflammation/Immunology
Avidin, chicken egg white is a glycoprotein derived from egg protein. Avidin, chicken egg white has excellent affinity with biotin and is often used in combination with biotin for immunoassays to detect the location of antigens in tissues .

m-PEG-NHS ester (MW 40000) mPEG-SC (MW 40000); mPEG-Succinimidyl ester (MW 40000)	Biochemical Assay Reagents	Others
m-PEG-NHS ester (MW 40000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects .

Ganglioside GM2	Others	Cancer
Ganglioside GM2 is a human tumor antigen (OFA-I-1). Ganglioside GM2 is the major lysosomal storage compound of Tay-Sachs disease .

HYNIC-PSMA	PSMA	Cancer
HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotinamide) and PSMA (Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules, such as ¹⁸⁸Re-HYNIC-PSMA. PSMA is a membrane antigen that is specifically expressed on the surface of prostate cancer cells. HYNIC-PSMA can be used in prostate cancer research .

SP-2-225	HDAC	Cancer
SP-2-225 is a selective HDAC6 inhibitor. SP-2-225 enhance the production of cancer-associated antigens and macrophage antigen cross-presentation to T cells. SP-2-225 reduces the tumor volume in a syngeneic SM1 melanoma model .

RU-25055	Glucocorticoid Receptor	Endocrinology
RU-25055 is a potent antiglucocorticoid. RU-25055 inhibits early antigen production of the EpsteinBarr virus (EBV) by dexamethasone .

(R)-Phe-A110/B319	Others	Metabolic Disease
(R)-Phe-A110/B319, a hapten, is a selective binder to tumor-associated antigens. (R)-Phe-A110/B319 has a 20-fold higher affinity towards the H1047R mutant of p110α in the p110α/p85α PI3K complex. (R)-Phe-A110/B319 can be used for the research of conditional chimeric antigen receptor T (CAR-T) cell activation and tumor targeting .

Asoxime dichloride HI-6	nAChR	Neurological Disease
Asoxime dichloride (HI-6) is an antagonist to acetylcholine receptors (AChRs) including the nicotinic receptor, α7 nAChR. Asoxime dichloride involves in modulating immunity response. Asoxime dichloride (HI-6) can be used as an antigen and improves vaccination efficacy in the nervous system .

Foravirumab CR4098	RABV	Infection
Foravirumab (CR4098) is a monoclonal antibody against rabies virus glycoprotein antigenic site III .

Estradiol 3-glucuronide	Endogenous Metabolite	Others
Estradiol 3-glucuronide is an immunogen with antigenic properties. Estradiol 3-glucuronide induced antiserum in the rabbit possesses high afinity and specifcity to Estradiol 3-glucuronide. Estradiol 3-glucuronide is promising for research of radioimmunoassay .

Glu-urea-Glu-NHS ester	PSMA	Cancer
Glu-urea-Glu-NHS ester (compound 21) is an activated N-hydroxysuccinamide (NHS) ester of Glu-urea-Glu which can be used as a pharmacophore for linking with prostate specific membrane antigen (PSMA) inhibitors .

O-Phthalimide-C1-S-C5-acid MFH	Biochemical Assay Reagents	Inflammation/Immunology
6-(N-Phthalimidoylmethylthio)hexanoic acid (MFH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-(N-Phthalimidoylmethylthio)hexanoic acid can be combined with carrier proteins and used in antigen design .

O-Phthalimide-C1-S-C1-acid MFA	Biochemical Assay Reagents	Inflammation/Immunology
2-(N-Phthalimidoylmethylthio)acetic acid (MFA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 2-(N-Phthalimidoylmethylthio)acetic acid can be combined with carrier proteins and used in antigen design .

O-Phthalimide-C5-acid	Biochemical Assay Reagents	Inflammation/Immunology
6-N-Phthalimidoy hexanoic acid (compound FH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-N-Phthalimidoy hexanoic acid can be combined with carrier proteins and used in antigen design .

O-Phthalimide-C3-acid 4-Phthalimidobutyric acid	Biochemical Assay Reagents	Inflammation/Immunology
4-(N-Phthalimidoyl)butanoic acid (compound FB) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 4-(N-Phthalimidoyl)butanoic acid can be combined with carrier proteins and used in antigen design .

Mannosamine–desthiobiotin adduct	Others	Inflammation/Immunology
Mannosamine-desthiobiotin adduct (compound MDTBA) is a carrier immunogenicity-reducing hapten that reduces the immunogenicity of protein carriers upon conjugation to available free amines on the carrier protein surface. Conjugation of Mannosamine-desthiobiotin adduct to hsIgG significantly (>1-fold) reduced the immunogenicity of hsIgG. Mannosamine-desthiobiotin adduct can be used in antigen design research .

Biotin-NH-PSMA-617	Fluorescent Dye	Cancer
Biotin-NH-PSMA-617 is a biotin-tagged PSMA-617. PSMA-617 is a small molecule targeting the prostate-specific membrane antigen (PSMA), which is directly expressed by the tumor cells .

Chlorphenesin	Bacterial Fungal	Inflammation/Immunology Cancer
Chlorphenesin is a reversible antigen-associated immunosuppressant. Chlorphenesin is an antibacterial and antifungal agent used in numerous eye care cosmetics .

Anetumab Anti-MSLN Antibody	Mesothelin	Cancer
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor .

Raxibacumab ABthrax	Bacterial	Infection
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .

4-Ketobenztriazine-CH2COOH	Biochemical Assay Reagents	Inflammation/Immunology
4-Ketobenztriazine-CH2COOH (compound BA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 4-Ketobenztriazine-CH2COOH can be combined with carrier proteins and used in antigen design .

Belantamab mafodotin GSK2857916; Belantamab mafodotin-blm	Antibody-Drug Conjugates (ADCs)	Cancer
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity .

DPPC 5 Publications Verification 129Y83	Liposome Endogenous Metabolite	Others
DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice .

3-(N-Phthalimidoylmethylthio)propanoic acid	Biochemical Assay Reagents	Inflammation/Immunology
3-(((1,3-Dioxoisoindolin-2-yl)methyl)thio)propanoic acid (MFP) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 3-(((1,3-Dioxoisoindolin-2-yl)methyl)thio)propanoic acid can be combined with carrier proteins and used in antigen design .

EBV EBNA3A (379-387)	EBV	Infection Inflammation/Immunology
EBV EBNA3A (379-387) is an antigenic epitope that may elicit the latent-specific CD8 ⁺ T cell response in HLA-B*07:02 ⁺ individuals .

Mogroside III A2	HSV	Infection
Mogroside III A2 is a cucurbitane glycoside. Mogroside III A2 can inhibit Epstein-Barr virus early antigen (EBV-EA) activation. Mogroside III A2 shows weak inhibitory effects on activation of NOR 1 .

Bocconoline	Others	Neurological Disease
Bocconoline is a potent *early endosome antigen* 1 (EEA1)** inhibitor. Bocconoline can be isolated from Macleaya cordata. Bocconoline can be used for the research of Parkinson’s disease (PD) .

di-DTPA-LTL	Others	Inflammation/Immunology Cancer
di-DTPA-LTL is a bivalent hapten based on tyrosine-containing polypeptide design. di-DTPA-LTL has good hydrophilia and biological distribution. di-DTPA-LTL is labeled with ¹¹¹In (indium) and ¹³¹I (iodine). di-DTPA-LTL achieves tumor radioimmunoimaging in primary colorectal cancer patients with CEA by injecting a fixed low dose (5 mg) of bispecific antibody (anti-CEA x, anti-DTPA) and di-DTPA antigen peptide (labeled ¹¹¹In) into the patients .

RL-6-Me-7-OH	Biochemical Assay Reagents	Inflammation/Immunology
RL-6-Me-7-OH is a hapten that activates human and mouse MAIT cells (EC₅₀=25µM). RL-6-Me-7-OH can be combined with carrier proteins and used in antigen design. RL-6-Me-7-OH can be used in inflammation and immunity research .

KRM-III	Nuclear Factor of activated T Cells (NFAT)	Inflammation/Immunology
KRM-III is a potent and orally active *T-cell antigen* receptor (TCR) inhibitor. KRM-III inhibits TCR- and phorbol myristate acetate/ionomycin-induced activation of nuclear factor of activated T cells (NFAT) and T-cell proliferation with an IC₅₀** of ~5 μM. Anti-inflammatory activity .

Tuvirumab anti-hepatitis B; OST 577; SDZ-OST 577	HBV	Infection
Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against *HBV surface antigen* (HBsAg)**. Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research .

4-Ketobenzotriazine-O-CH2-COOH HBA	Biochemical Assay Reagents	Inflammation/Immunology
2-[(4-Oxo-1,2,3-benzotriazin-3-yl)oxy]acetic acid (HBA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 2-[(4-Oxo-1,2,3-benzotriazin-3-yl)oxy]acetic acid can be combined with carrier proteins and used in antigen design .

4-Ketobenzotriazine-CH2-S-(CH2)5-COOH MBH	Biochemical Assay Reagents	Inflammation/Immunology
6-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]hexanoic acid (MBH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]hexanoic acid can be combined with carrier proteins and used in antigen design .

4-Ketobenzotriazine-CH2-S-(CH2)2-COOH MBP	Biochemical Assay Reagents	Inflammation/Immunology Cancer
3-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]propanoic acid (MBP) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 3-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]propanoic acid can be combined with carrier proteins and used in antigen design .

Chlorphenesin (Standard)	Bacterial Fungal	Inflammation/Immunology Cancer
Chlorphenesin (Standard) is the analytical standard of Chlorphenesin. This product is intended for research and analytical applications. Chlorphenesin is a reversible antigen-associated immunosuppressant. Chlorphenesin is an antibacterial and antifungal agent used in numerous eye care cosmetics .

Cat. No.	Product Name

HY-L172

Immunopotentiator Compound Library

90 compounds

Immunity refers to the ability of the body to resist the invasion of pathogenic microorganisms and resist a variety of diseases. Immunocompromised will inevitably lead to a series of diseases. Immunopotentiator are a class of compounds that enhance immune function and induce immune response. Immunopotentiator can activate the proliferation and differentiation of one or more kinds of immune active cells in the body, promote the secretion of lymphocytes, and then enhance the immune function of the body. Immunopotentiator are mainly used in the treatment of tumors, infectious diseases and immunodeficiency diseases. In addition, immunopotentiator are often used as adjuvants in combination with vaccine antigens to enhance the immunogenicity of vaccines.

MCE designs a unique collection of 90 compounds with definite or potential Immunopotentiating effect, mainly targeting the NOD-like Receptor (NLR), Toll-like Receptor (TLR), NF-κB, etc. It is an effective tool for development and research of anti-cancer, anti-infectious diseases and anti-immunodeficiency diseases compounds.

HY-L076

Drug-Induced Liver Injury (DILI) Compound Library

1,444 compounds

Drug-induced liver injury (DILI; also known as drug-induced hepatotoxicity) is caused by medications (prescription or OTC), herbal and dietary supplements (HDS), or other xenobiotics that result in abnormalities in liver tests or in hepatic dysfunction that cannot be explained by other causes. Drugs are an important cause of liver injury. Drug-induced hepatic injury is the most common reason cited for withdrawal of an approved drug.

DILI is thought to occur via several different mechanisms. Among these are direct impairment of the structural (e.g., mitochondrial dysfunction) and functional integrity of the liver; production of a metabolite that alters hepatocellular structure and function; production of a reactive drug metabolite that binds to hepatic proteins to produce new antigenic drug-protein adducts, which are targeted by hosts’ defenses (the hapten hypothesis); and initiation of a systemic hypersensitivity response (i.e., drug allergy) that damages the liver.

MCE Drug-induced Liver Injury (DILI) Compound Library contains a unique collection of 1,444 hepatotoxicity causing compounds and is a powerful tool to research DILI and other drug toxicities. This library can be used to understand the mechanisms of DILI, identify biomarkers for early DILI prediction, and allow timely recognition during drug development, thus finally achieving successful DILI prevention and assessment in the pre-marketing phase.

Cat. No.	Product Name	Type

HY-12489

Ponceau S Acid Red 112	Dyes
Ponceau S (Acid Red 112) is a non-specific protein dye commonly used as a stain for Western blot. Ponceau S is used in an acidic aqueous solution that is compatible with antibody-antigen binding and dyes the proteins on the membrane red .

HY-D1832

Vari Fluor 532 TSA (200×) VF 532 Tyramide	Dyes
Vari Fluor 532 TSA (200×) (VF 532 Tyramide) is a fluorescent probe belonging to the Vari Fluor TSA series. Vari Fluor TSA series fluorescent probes can be used for high-density in situ labeling of target antigens using horseradish peroxidase (HRP) assays, which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-D1833

Vari Fluor 680 TSA (200×) VF 680 Tyramide	Dyes
Vari Fluor 680 TSA (200×) (VF 680 Tyramide) is a fluorescent probe belonging to the Vari Fluor TSA series. Vari Fluor TSA series fluorescent probes can be used for high-density in situ labeling of target antigens using horseradish peroxidase (HRP) assays, which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-D1834

Vari Fluor 640 TSA（200×） VF 640 Tyramide	Dyes
Vari Fluor 640 TSA（200×） (VF 640 Tyramide) is a fluorescent probe belonging to the Vari Fluor TSA series. Vari Fluor TSA series fluorescent probes can be used for high-density in situ labeling of target antigens using horseradish peroxidase (HRP) assays, which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-D1835

Vari Fluor 594 TSA（200×） VF 594 Tyramide	Dyes
Vari Fluor 594 TSA（200×） (VF 594 Tyramide) is a fluorescent probe belonging to the Vari Fluor TSA series. Vari Fluor TSA series fluorescent probes can be used for high-density in situ labeling of target antigens using horseradish peroxidase (HRP) assays, which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-D1831

Vari Fluor 620 TSA（200×） VF 620 Tyramide	Dyes
Vari Fluor 620 TSA（200×） (VF 620 Tyramide) is a fluorescent probe belonging to the Vari Fluor TSA series. Vari Fluor TSA series fluorescent probes can be used for high-density in situ labeling of target antigens using horseradish peroxidase (HRP) assays, which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-156087G

Cholicamideβ (GMP)

Fluorescent Dye

Cholicamideβ (GMP) is a GMP grade of Cholicamideβ. Cholicamideβ (compound 6) is a self-assembling, small molecule, cancer vaccine adjuvant. Cholicamideβ can form virus-like particles with low cytotoxicity. Cholicamideβ, upon binding to peptide antigens, enhances antigen presentation by dendritic cells and induces antigen-specific T cells. Cholicamideβ can induce apoptosis and necrosis .

HY-D2396

Sulfo SMCC R-phycoerythrin Sulfo SMCC R-PE	Dyes
Sulfo SMCC R-phycoerythrin is a conjugate composed of the protein crosslinker SMCC (HY-42360) and R-PE (R-Phycoerythrin) (HY-D0988) that can be used to label proteins to make them carry red fluorescence. Among them, SMCC is able to engage antigen-coupled spleen cells to induce antigen-specific immune responses .

HY-153209G

ISATM51 (GMP)	Fluorescent Dye
ISATM51 (GMP) is a GMP grade ISATM51. ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .

HY-153205G

Aluminum hydroxide adjuvant (GMP)	Fluorescent Dye
Aluminum hydroxide adjuvant (GMP) is Aluminum hydroxide adjuvant produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Aluminum hydroxide adjuvant is a vaccine adjuvant. Aluminum hydroxide adjuvant induces the differentiation of macrophages into a new type of mature, specialized antigen-presenting cells in vitro .

HY-D1837

Vari Fluor 488 TSA（200×） VF 488 Tyramide	Dyes
Vari Fluor 488 TSA（200×） (VF 488 Tyramide) is a fluorescent probe belonging to the Vari Fluor TSA series. Vari Fluor TSA series fluorescent probes can be used for high-density in situ labeling of target antigens using horseradish peroxidase (HRP) assays, which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-D1838

Vari Fluor 350 TSA（200×） VF 350 Tyramide	Dyes
Vari Fluor 350 TSA（200×） (VF 350 Tyramide) is a fluorescent probe belonging to the Vari Fluor TSA series. Vari Fluor TSA series fluorescent probes can be used for high-density in situ labeling of target antigens using horseradish peroxidase (HRP) assays, which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-D1836

Vari Fluor 555 TSA (200x) VF 555 Tyramide	Dyes
Vari Fluor 555 TSA (200x) , also know as VF 555 Tyramide. Vari Fluor 555 TSA (200x) is one of Vari Fluor TSA series fluorescent probes, which can be used for high-density in situ labeling assays. Vari Fluor TSA series target antigens via horseradish peroxidase (HRP), which are widely used in ELISA, IF, IHC and other techniques with high detection sensitivity .

HY-W415108

10-Methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonate

Fluorescent Dyes/Probes

10-Methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonate is an acridinium ester that produces fluorescent 10-methyl-9-acridone upon oxidation with hydrogen peroxide, persulfate, and other oxidants under alkaline conditions. 10-Methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonate can be used in chemiluminescent assays, enzyme, antigen, antibody, and hormone immunoassays, and for the detection of oxidants in environmental, biological, and pharmaceutical samples .

HY-D0948

Celestine Blue

Dyes

Celestine Blue is a electroactive indicator in DNA biosensors. Celestine Blue is strongly adsorbed on the spinel phases and CNT (carbon nanotubes), facilitates dispersion, acts as a capping agent and allows for the fabrication of spinel decorated CNT. Celestine Blue is an efficient charge transfer mediator, which allows for significant improvement of capacitive behavior. TiO₂ nanoparticles doped with Celestine Blue can be used as a label in a sandwich immunoassay for the hepatitis C virus (HCV) core antigen .

HY-W127716

Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 1 Publications Verification	Fluorescent Dyes/Probes
Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 is a potent ruthenium-based dye. Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 can bu used as an effective quencher of quantum dots (QDs) fluorescence and the capture probe of virus antigen EV71. Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 can be used sensitive electrogenerated chemiluminescence (ECL) labels for detection of matrix metalloproteinases (MMPs) .

Cat. No.	Product Name	Type

HY-NP005

Avidin, chiken egg white	Native Proteins
Avidin, chicken egg white is a glycoprotein derived from egg protein. Avidin, chicken egg white has excellent affinity with biotin and is often used in combination with biotin for immunoassays to detect the location of antigens in tissues .

HY-NP138

NP-OVAL (Ovalbumin)	Native Proteins
NP-OVAL (Ovalbumin) is an immunoconjugate. NP-OVAL (Ovalbumin) is used as a model antigen for the study of multiple myeloma .

HY-109506

DPPC 5 Publications Verification 129Y83	Drug Delivery
DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice .

HY-NP017

*Prostate specific antigen* protein (human)** PSA; Native human prostate specific Antigen protein	Native Proteins
Prostate specific antigen protein (human) is a serine protease which produced by prostatic epithelium. Prostate specific antigen protein (human) can be used to study prostatic cancer .

HY-E70158

Fucosyltransferase 9 EC:2.4.1.152; FUT9	Enzyme Substrates
Fucosyltransferase 9 (EC:2.4.1.152, FUT9) catalyzes the last step in the biosynthesis of Lewis antigen, the addition of a fucose to precursor polysaccharides. Fucosyltransferase 9 synthesizes the LeX oligosaccharide (CD15) .

HY-109506R

DPPC (Standard)

Drug Delivery

DPPC (Standard) is the analytical standard of DPPC. This product is intended for research and analytical applications. DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice .

HY-163556

COT/BSA	Biochemical Assay Reagents
COT/BSA is the antigen-adjuvant conjugate of COT (cyclooctatetraene) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161529

Angiotensin I/BSA	Biochemical Assay Reagents
Angiotensin I/BSA is an antigen-adjuvant conjugate of Angiotensin I and bovine serum albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161553

Biotin/KLH

Biochemical Assay Reagents

Biotin/KLH is an antigen-adjuvant conjugate that consists of Biotin and Keyhole Limpet Hemocyanin (KLH). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161554

Clenbuterol/BSA

Biochemical Assay Reagents

Clenbuterol/BSA is an antigen-adjuvant conjugate of Clenbuterol (HY-B1615) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, it can enhance the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-163553

Metronidazole/BSA

Biochemical Assay Reagents

Metronidazole/BSA is an antigen-adjuvant conjugate of Metronidazole (HY-B0318) and Bovine Serum Albumin (BSA). By conjugating the antigen with the protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.

HY-161530

Angiotensin II/BSA

Biochemical Assay Reagents

Angiotensin II/BSA is an antigen-adjuvant conjugate formed by the coupling of Angiotensin II with bovine serum albumin (BSA). By coupling the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161594

Furazolidone/BSA

Biochemical Assay Reagents

Furazolidone/BSA is the antigen-adjuvant conjugate of Furazolidone (HY-B1336) and bovine serum albumin (BSA). By conjugating the antigen with the protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161585

Diethylstilbestrol/KLH

Biochemical Assay Reagents

Diethylstilbestrol/KLH is an antigen-adjuvant conjugate formed by the coupling of Diethylstilbestrol (HY-14598) with Keyhole Limpet Hemocyanin (KLH). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161586

Chloramphenicol/BSA

Biochemical Assay Reagents

Chloramphenicol/BSA is the antigen-adjuvant conjugate formed by the coupling of Chloramphenicol (HY-B0239) with Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-163551

BNP peptide/KLH

Biochemical Assay Reagents

The BNP peptide/KLH is an antigen-adjuvant conjugate formed by linking BNP peptide (human brain natriuretic peptide) with keyhole limpet hemocyanin (KLH). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or damage the major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161545

Sudan I/BSA

Biochemical Assay Reagents

Sudan I/BSA is the antigen-adjuvant conjugate formed by Sudan I (HY-D0024) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161565

Gastrin(1-17)/BSA

Biochemical Assay Reagents

Gastrin(1-17)/BSA is an antigen-adjuvant conjugate formed by the coupling of Gastrin(1-17) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or destroy major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.

HY-163552

Prostaglandin F2a/BSA

Biochemical Assay Reagents

Prostaglandin F2a/BSA is an antigen-adjuvant conjugate formed by the conjugation of Prostaglandin F2a with Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation as well as the generation of antigen-specific T cells.

HY-161551

25-OH Vitamin D3/KLH

Biochemical Assay Reagents

25-OH Vitamin D3/KLH is an antigen-adjuvant conjugate of 25-OH Vitamin D3 (HY-158285) and Keyhole Limpet Hemocyanin (KLH). By conjugating the antigen with the protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-161587

Chloramphenicol/OVA	Biochemical Assay Reagents
Chloramphenicol/OVA is a conjugate of Chloramphenicol (HY-B0239) and Ovalbumin (OVA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation and the production of antigen-specific T cells.

HY-161581

Metronidazole/OVA	Biochemical Assay Reagents
Metronidazole/OVA is a conjugate of Metronidazole (HY-B0318) and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-D1056

Lipopolysaccharides, from E. coli O55:B5

Maximum Cited Publications

213 Publications Verification

LPS

Carbohydrates

Lipopolysaccharides, from E. coli O55:B5 is an endotoxin extracted from E. coli O55:B5, consisting of an antigen-specific chain, A core oligosaccharide, and lipid A. Lipopolysaccharides, from E. coli O55:B5 activates TLR-4 of immune cells. Lipopolysaccharides, from E. coli O55:B5 can induce the change of body temperature in rats with dose and serotype specificity. Lipopolysaccharides, from E. coli O55:B5 caused a heterogeneous and dose-independent increase in body temperature in rats .

HY-156087G

Cholicamideβ (GMP)

Biochemical Assay Reagents

HY-D1056C3

Lipopolysaccharides, from S. enterica serotype typhimurium

LPS, from Salmonella enterica (Serotype typhimurium)

Carbohydrates

Lipopolysaccharides, from S. enterica serotype typhimurium, are a kind of lipid-polysaccharide endotoxin. Smooth Gram-negative bacteria's lipopolysaccharides are made up of three components: lipid A, core oligosaccharide, and O antigen (OAg). The O antigen is a polymer of sugar repeat units (RUs); the Wzz protein regulates the length of the O antigen in lipopolysaccharides, and the number of RUs attached to lipid A is determined by the modal value set by the Wzz protein. S. enterica typhimurium has two Wzz proteins: Wzz_ST (which makes the modal range of the O antigen between 16 and 35 RUs) and Wzz_fepE (which makes the modal value over 100 RUs). Mutating the genes corresponding to these two proteins causes the formation of short-chain O antigen chains and significantly reduces bacterial pathogenicity .

HY-153234

CD19 car circRNA-LNP

Drug Delivery

CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .

HY-153233

CD19 car mRNA (Mouse)-LNP

Drug Delivery

CD19 car mRNA (Mouse)-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .

HY-B1250

Acedoben	Biochemical Assay Reagents
Acedoben is a biochemical agent. Acedoben and iron ions can construct a fast self-assembled coordination complex. The Fe-Ace coordination complex can not only serve as a carrier of tumor antigens, but also enhance antigen-specific anti-tumor immunity due to its inherent adjuvant properties .

HY-B1250A

Acedoben sodium	Cell Assay Reagents
Acedoben sodium is the sodium salt form of Acedoben. Acedoben and iron ions can construct a rapidly self-assembled coordination complex, and the Fe-Ace coordination complex can not only serve as a carrier of tumor antigens, but also enhance antigen-specific anti-tumor immunity due to its inherent adjuvant properties .

HY-E70156

Fucosyltransferase 7 EC:2.4.1.-; FUT7	Enzyme Substrates
Fucosyltransferase 7 (FUT7) is a golgi stack membrane protein. Fucosyltransferase 7catalyzes the final fucosylation step in the synthesis of Lewis antigens and generates a unique glycosylated product sialyl Lewis X (sLeX). Fucosyltransferase 7 catalyzes alpha-1,3 glycosidic linkages involved in the expression of sialyl Lewis X antigens .

HY-161525

1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid linker/BSA

Biochemical Assay Reagents

1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid linker/BSA is the conjugate of 1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid linker (1-(2-氨基乙基)-1H-吡唑-4-基膦酸连接子) and bovine serum albumin (BSA). By conjugating the antigen with a protein adjuvant, it enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or disrupt key epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.

HY-NP052

Ovalbumin-Biotin OVA-Biotin	Native Proteins
Ovalbumin-Biotin is a biotinylated biochemical reagent. Ovalbumin-Biotin is used to label or detect specific antigens, molecules or cellular structures .

HY-B1250R

Acedoben (Standard)

Biochemical Assay Reagents

Acedoben (Standard) is the analytical standard of Acedoben. This product is intended for research and analytical applications. Acedoben is a biochemical agent. Acedoben and iron ions can construct a fast self-assembled coordination complex. The Fe-Ace coordination complex can not only serve as a carrier of tumor antigens, but also enhance antigen-specific anti-tumor immunity due to its inherent adjuvant properties .

HY-NP037

Avidin-HRP	Native Proteins
Avidin-HRP is Horseradish Peroxidase (HRP) Avidin. Avidin has excellent affinity with biotin and is often used in combination with biotin for immunoassays to detect the location of antigens in tissues .

HY-NP045

Protein A-RBITC	Native Proteins
Protein A-RBITC is a biochemical reagent conjugated to fluorescein PE. Protein A-RBITC can be used to label or detect specific antigens, molecules or cellular structures .

HY-E70155

Fucosyltransferase 5 EC:2.4.1.65; Fucosyltransferase 5; Fucosyltransferase V	Enzyme Substrates
Fucosyltransferase 5 (EC:2.4.1.65, Fucosyltransferase 5, Fucosyltransferase V) is responsible for the terminal step in the synthesis of Lex, sialy-Lex, and Lea antigens .

HY-153209G

ISATM51 (GMP)	Biochemical Assay Reagents
ISATM51 (GMP) is a GMP grade ISATM51. ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .

HY-158272

Penicillin/OVA	Biochemical Assay Reagents
Penicillin/OVA is a conjugate of penicillin and Ovalbumins (HY-W250978), that is utilized as an antigen in immunological research. Penicillin/OVA causes IgE-dependent anaphylactic response to penicillin in mice .

HY-NP043

Avidin-Cy3	Native Proteins
Avidin-Cy3 is Cy3-labeled Avidin. Avidin has excellent affinity with biotin and is often used in combination with biotin for immunoassays to detect the location of antigens in tissues .

HY-D1056A3

Lipopolysaccharides, from E. coli O26:B6

LPS, from Escherichia coli (O26:B6)

Carbohydrates

Lipopolysaccharides, from E. coli O26:B6 is a lipopolysaccharide endotoxin and TLR-4 activator that activates the disease-related molecular pattern (PAMP) of the immune system and induces cell secretion of migratory bodies. Lipopolysaccharides, from E. coli O26:B6 consists of an antigen-specific O-chain, some cells lack an O-antigen-side chain, and is recognized by the core-specific monoclonal antibody MAb J8-4C10 .

HY-NP041

Bovine Serum Albumin-PE BSA-PE	Native Proteins
Bovine Sermu Albumin-PE is a biochemical reagent conjugated to fluorescein PE (Ex=565 nm; Em=578 nm). Bovine Sermu Albumin-PE can be used to label or detect specific antigens, molecules or cellular structures .

HY-NP058

Ovalbumin-AF594 OVA-AF594	Native Proteins
Ovalbumin-AF594 is a biochemical reagent conjugated to fluorescein AF594 (Ex=590 nm; Em=617 nm). Ovalbumin-AF594 can be used to label or detect specific antigens, molecules or cellular structures .

HY-NP051

Bovine Serum Albumin-FITC	Native Proteins
Bovine Sermu Albumin-FITC is a bovine serum albumin conjugated to FITC (Ex=495 nm; Em=525 nm). Bovine Sermu Albumin-FITC can be used as a fluorescent marker to label or detect specific antigens, molecules or cellular structures .

HY-B1610L

Sodium Citrate Buffer, 0.5M, pH 6.0	Buffer Reagents
Sodium citrate buffer, 0.5M, pH 6.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 6.0 is used for RNA isolation and antigens detection in fixed tissue .

HY-D1056C1

Lipopolysaccharides, from S. enterica serotype enteritidis

LPS, from Salmonella enterica (Serotype enteritidis)

Carbohydrates

Lipopolysaccharides, from S. enterica serotype enteritidis is a lipopolysaccharide endotoxin that causes gastrointestinal disease in humans and can be transmitted through contaminated eggs or foods based on eggs and poultry meat products. S. enterica serotype enteritidis is capable of producing high molecular weight LPS-O antigen chains, Lipopolysaccharides, from S. enterica serotype typhimurium (HY-D1056C3) did not. S. enterica serotype enteritidis is similar to other pathogenic Salmonella. Lipopolysaccharides, from S. enterica serotype enteritidis' O antigen is associated with phage attachment in the early stages of phage infection S. Enteritidis .

HY-NP059

Ovalbumin-AF647 OVA-AF647	Native Proteins
Ovalbumin-AF647 is an ovalbumin conjugated with the far-red fluorescent dye AF647 (Ex=650 nm; Em=665 nm). Ovalbumin-AF647 can be used as a fluorescent label to label or detect specific antigens, molecules or cellular structures .

HY-NP060

Human Serum Albumin-AF488 HSA-AF488	Native Proteins
Human Serum Albumin-AF488 is a biochemical reagent conjugated to fluorescein AF488 (Ex=488 nm; Em=496 nm). Human Serum Albumin-AF488 can be used to label or detect specific antigens, molecules or cellular structures .

HY-W054292

tert-Butyl-DCL	Biochemical Assay Reagents
tert-Butyl-DCL is a small molecule PSMAM inhibitor with anticancer activity that targets prostate-specific membrane antigen (PSMA). tert-Butyl-DCL is also an effective bioimaging agent that has high selectivity and affinity, allowing it to target and highlight specific receptors on the surface of tumor cells .

HY-NP027

Human Serum Albumin-Cy3 HSA-Cy3	Native Proteins
Human Serum Albumin-Cy3 is a human serum albumin conjugated with Cy3 (Ex=554 nm; Em=568 nm). Human Serum Albumin-Cy3 can be used as a fluorescent marker to label or detect specific antigens, molecules or cell structures .

HY-155909

m-PEG-NHS ester (MW 3400) mPEG-SC (MW 3400); mPEG-Succinimidyl ester (MW 3400)	Drug Delivery
m-PEG-NHS ester (MW 3400) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.

Cat. No.	Product Name	Target	Research Area

HY-P0310

*SV40 large T antigen* NLS**	Peptides	Infection
SV40 large T antigen NLS is from Large T antigen residue 47 to 55, enables protein import into cell nucleus.

HY-P0277

*Carcinoembryonic antigen* peptide 1** CEA peptide	Peptides	Cancer
Carcinoembryonic antigen peptide 1 (CEA peptide) is a carcinoembryonic antigen (CEA)-derived peptide. Carcinoembryonic antigen peptide 1 is a potential HLA-A*0201-restricted CTL epitope that can be used for the study of CTL-mediated epithelial-derived cancers .

HY-P2494

OVA (55-62)	Peptides	Inflammation/Immunology
OVA 55-62 is a fragmented peptide of OVA (ovalbumin) antigen and can bind to the mouse MHC class I molecule, H2-Kb .

HY-P5290

HYNIC-PSMA	PSMA	Cancer
HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotinamide) and PSMA (Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules, such as ¹⁸⁸Re-HYNIC-PSMA. PSMA is a membrane antigen that is specifically expressed on the surface of prostate cancer cells. HYNIC-PSMA can be used in prostate cancer research .

HY-P10507

MART-1 nonamer antigen	Peptides	Cancer
MART-1 nonamer antigen (LAGIGILTV) is a melanoma antigen that can be recognized by T cells. MART-1 nonamer antigen behaves as a superagonist by in vitro inducing specific T cells with enhanced immunological functions. MART-1 nonamer antigen can be used as a model to design peptides for use in anti-tumour vaccines .

HY-P3640

*MAGE-3 Antigen* (167-176) (human)**	Peptides	Cancer
MAGE-3 Antigen (167-176) (human) is a polypeptide containing eight amino acids. MAGE-3 Antigen (167-176) (human) is a human leukocyte antigen HLA-B44 molecules epitope encoded by melanoma antigen gene (MAGE) .

HY-P5990

*Prostate Specific Antigen* Substrate**	PSMA	Cancer
Prostate Specific Antigen Substrate is a prostate specific antigen (PSA) fluorescent substrate. Prostate Specific Antigen Substrate can be used for detect enzymatic activity of PSA .

HY-P4156

VLVNTFCDSCIPKTYWNLGY TFA	mAChR	Neurological Disease
VLVNTFCDSCIPKTYWNLGY TFA is an antigenic peptide of M3 muscarinic receptor (M3R). VLVNTFCDSCIPKTYWNLGY TFA can be used in ELISA .

HY-P5972

GRP20–29, frog	Peptides	Cancer
GRP20–29, frog is a 10-amino acid antigen peptide that can be isolated from Xenopus .

HY-P10664

EBV EBNA3B (416-424)	Peptides	Inflammation/Immunology
EBV EBNA3B (416-424) is an HLA-A11-restricted peptide antigen derived from EBV EBNA3B protein .

HY-P10512

BDC2.5 mimotope	Peptides	Others
BDC2.5 mimotope is a potent antigen-mimicking peptide that can activate CD4+ T cell populations that have the same antigen recognition properties as BDC2.5 cells. BDC2.5 mimotope can be used to study the prevention or treatment of type 1 diabetes by targeting specific T cell populations .

HY-P2695

STh	Peptides	Infection
STh, an Escherichia coli heat-stable toxin, is a 19 amino acid polypeptide encompassing three disulfide bridges. STh is an antigen of interest in the search for a broad coverage enterotoxigenic Escherichia coli (ETEC) vaccine .

HY-P1917

Uty HY Peptide (246-254)	Peptides	Inflammation/Immunology
Uty HY Peptide (246-254), derived from the ubiquitously transcribed tetratricopeptide repeat gene on the Y chromosome (UTY) protein as an H-Y epitope, H-YD ^b, is a male-specific transplantation antigen H-Y .

HY-P3727

Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr	Peptides	Inflammation/Immunology
Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr is a undecapeptide, corresponding to the carboxy terminus of simian virus 40 large T antigen. Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr can be targeted by antibodies secreted from three mouse hybridomas, designated KT1, KT3, and KT4, produced antibodies that immunoprecipitated large T antigen .

HY-P1876

NLS (PKKKRKV)	Peptides	Cancer
NLS (PKKKRKV) is a nuclear localization signal (NLS) derived from the simian virus 40 large tumor antigen (SV40 large T antigen), that mediates binding of the karyophilic protein to importin α. NLS (PKKKRKV) can function as a method to enhance nuclear entry in the field of gene transfer research .

HY-12523

Peptide M	Peptides	Others
Peptide M is a synthetic amino acid (18 amino acids in length which correspond to the amino acid positions 303-322 of bovine S-antigen: DTNLASSTIIKEGIDKTV), is capable of inducing experimental autoimmune uveitis in monkeys and Hartley guinea pigs as well as Lewis rats .

HY-P2524

MAGE-3 (271-279)	Peptides	Cancer
MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta .

HY-P1917A

Uty HY Peptide (246-254) (TFA)	Peptides	Inflammation/Immunology
Uty HY Peptide (246-254) TFA, derived from the ubiquitously transcribed tetratricopeptide repeat gene on the Y chromosome (UTY) protein as an H-Y epitope, H-YD ^b, is a male-specific transplantation antigen H-Y .

HY-P1876B

NLS (PKKKRKV) (hydrochloride)	Peptides	Cancer
NLS (PKKKRKV) hydrochloride is the hydrochloride form of NLS (PKKKRKV) (HY-P1876). NLS (PKKKRKV) is a nuclear localization signal (NLS) derived from the simian virus 40 large tumor antigen (SV40 large T antigen), that mediates binding of the karyophilic protein to importin α. NLS (PKKKRKV) can function as a method to enhance nuclear entry in the field of gene transfer research .

HY-P1876A

NLS (PKKKRKV) (TFA)	Peptides	Cancer
NLS (PKKKRKV) TFA is the TFA form of NLS (PKKKRKV) (HY-P1876). NLS (PKKKRKV) is a nuclear localization signal (NLS) derived from the simian virus 40 large tumor antigen (SV40 large T antigen), that mediates binding of the karyophilic protein to importin α. NLS (PKKKRKV) can function as a method to enhance nuclear entry in the field of gene transfer research .

HY-P3827

Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly	Peptides	Inflammation/Immunology
Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly is a13-mer synthetic peptide containing seven amino acids homologous to SV40 T antigen. Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly is capable of inducing nuclear transport .

HY-P10663

EBV EBNA3A (379-387)	EBV	Infection Inflammation/Immunology
EBV EBNA3A (379-387) is an antigenic epitope that may elicit the latent-specific CD8 ⁺ T cell response in HLA-B*07:02 ⁺ individuals .

HY-P4193

AH1	Peptides	Inflammation/Immunology
AH1 is an immunodominant antigen derived from the gp70 product of an endogenous MuLV. AH1 behaves as the CTL-immunodominant epitope of CT26 colon carcinoma .

HY-P2525

GAD65 (206-220)	Peptides	Inflammation/Immunology
GAD65 (206-220) is glutamic acid decarboxylase (GAD) 65-derived peptide, corresponding to residues 180-188. GAD65 is presented to T cells in association with I-Ag7 MHC class II molecules and a major pancreatic antigens targeted by self-reactive T cells in type I diabetes mellitus .

HY-P10339

SMCY peptide	Peptides	Inflammation/Immunology
SMCY peptide inhibits the binding of iodinated standard peptide to HLA-B7 with an IC₅₀ of 34 nM. As an epitope of the H-Y antigen, SMCY peptide can be presented by the HLA-B7 molecule and recognized by specific T cells, leading to transplant rejection .

HY-P5930

HOXB7 8–25 MDM2 32-46	Ligands for E3 Ligase	Cancer
HOXB7 8–25 (MDM2 32-46) is an MDM2-derived peptide epitope and can elicit antigen-specifc and tumor-reactive CD4 ⁺ T cell responses .

HY-P10315

[Gln144]-PLP (139-151) Q144-PLP(139-151)	Peptides	Others
[Gln144]-PLP (139-151) is an experimental antigen used to study T cells respond to both autoantigens and cross-reactive non-autoantigens. [Gln144]-PLP (139-151) activates T cells by binding to T-cell Receptor (TCR), which triggers an immune response. [Gln144]-PLP (139-151) can be used to study the regulation of autoimmune diseases .

HY-P10496

MAGE-A1-derived peptide	Peptides	Cancer
MAGE-A1-derived peptide is a short peptide sequence derived from MAGE-A1 protein. As a tumor-specific antigen, MAGE-A1-derived peptide can be recognized and activated by cytotoxic T lymphocytes (CTLs), thereby generating an immune response to tumor cells expressing MAGE-A1. This immune response can lead to the lysis and death of tumor cells. MAGE-A1-derived peptide can be used in the study of tumor immunity .

HY-P4155

SSA antigenic peptide	Peptides	Inflammation/Immunology
SSA antigenic peptide is an antigenic peptide of Sjögren’s syndrome-related antigen A (SSA) .

HY-P1842

MAGE-A3 (195-203)	Peptides	Cancer
MAGE-A3 (195-203) is a human leukocyte antigen (HLA) -A24 molecules epitope encoded by melanoma antigen gene (MAGE) .

HY-P5623B

RVG TFA RVG29 TFA; RDP TFA; Rabies Virus Glycoprotein-29 TFA	Bacterial	Infection
RVG TFA is a peptide derived from Rabies Virus Glycoprotein that binds to the α-7 subunit of nicotinic acetylcholine receptors (AchR) of neuronal cells. RVG enhances delivery of Mycobacterium tuberculosis antigens to antigen-presenting cells .

HY-P5623

RVG RVG29; RDP; Rabies Virus Glycoprotein-29	Bacterial	Infection
RVG (RVG29) is a peptide derived from Rabies Virus Glycoprotein that binds to the α-7 subunit of nicotinic acetylcholine receptors (AchR) of neuronal cells. RVG enhances delivery of Mycobacterium tuberculosis antigens to antigen-presenting cells .

HY-P5304A

RTQLLWTPAAPTAMA TFA	Peptides	Inflammation/Immunology
RTQLLWTPAAPTAMA TFA is a peptide antigen，used for drug delivery in immune response .

HY-P1700

BCMA72-80	Peptides	Cancer
BCMA72-80 is a HLA-A2-specific B-cell maturation antigen (BCMA) peptide, with great affinity to HLA-A2, used in the research of multiple myeloma or other B-cell maturation antigen expressing tumors .

HY-P1813

PSA1 (141-150) PSA-Peptide	Peptides	Cancer
PSA1 (141-150), a prostate specific antigen 1 peptide, is used in the immunotherapy of cancer experiments .

HY-P3590

PQDVKFP	HCV	Others
PQDVKFP is a synthetic peptide, recognizing antigenic domains within the hepatitis C virus (HCV) core protein .

HY-P2495

OVA (241-270)	Peptides	Cancer
OVA (241-270), a non-specific cytotoxic T lymphocyte (CTL) peptide, is a fragmented peptide of OVA (ovalbumin) antigen .

HY-P2495A

OVA (241-270) (TFA)	Peptides	Inflammation/Immunology
OVA (241-270) TFA, a non-specific cytotoxic T lymphocyte (CTL) peptide, is a fragmented peptide of OVA (ovalbumin) antigen .

HY-P4050

HBV Seq1 aa:18-27	HBV	Infection
HBV Seq1 aa:18-27 is a hepatitis B virus (HBV) core antigen 18-27 peptide fragment .

HY-P4048

HBV Seq1 aa:93-100	HBV	Infection
HBV Seq1 aa:93-100 is a hepatitis B virus (HBV) core antigen 93-100 peptide fragment .

HY-P10250

HIV gp120 (308-331)	HIV	Inflammation/Immunology
HIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody .

HY-P2511

Insulin β Chain Peptide (15-23)	Peptides	Metabolic Disease
Insulin β Chain Peptide (15-23) is one of the earliest antigenic epitopes to which CD8 T-cells respond .

HY-P3823

Asp-Asp-Asp-Asp-Asp-Asp	Influenza Virus	Infection
Asp-Asp-Asp-Asp-Asp-Asp is a polyaspartic acid. The specificity of the catalytic and antigenic sites of influenza virus neuraminidase is related to the number of specific amino acids.

HY-P5276

Human membrane-bound PD-L1 polypeptide	PD-1/PD-L1	Cancer
Human membrane-bound PD-L1 polypeptide can be used as an antigen to induce PD-L1 antibody production .

HY-P10252

HIV gp120 (421-438)	HIV	Inflammation/Immunology
HIV gp120 421-438 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody .

HY-P3823A

Asp-Asp-Asp-Asp-Asp-Asp TFA	Influenza Virus	Infection
Asp-Asp-Asp-Asp-Asp-Asp TFA is a polyaspartic acid. The specificity of the catalytic and antigenic sites of influenza virus neuraminidase is related to the number of specific amino acids.

HY-P10509

IE1 peptide	Peptides	Infection
IE1 peptide refers to an antigenic peptide encoded by the immediate early (IE) gene of mouse cytomegalovirus (mCMV). IE1 peptide is one of the key antigenic peptides expressed during mCMV infection, plays a role in transcriptional activation in the life cycle of mCMV, and is one of the earliest genes expressed in the viral replication cycle. IE1 peptide is an important target for CD8+ T cell response and can be used to study the host immune response to mCMV infection .

HY-P10263

MAGE-1 nonapeptide MAGE-1(161-169), human	Peptides	Others
MAGE-1 nonapeptide (MAGE-1 (161-169), human) is a radioiodinated photoreactive derivative from MAGE-1 encoded melanoma tumor antigen .

HY-W101889

Boc-Gln(Xan)-OH N-Boc-N'-xanthyl-L-glutamine	Amino Acid Derivatives	Others
Boc-Gln(Xan)-OH (N-Boc-N'-xanthyl-L-glutamine) is an amino acid derivative with a Boc protecting group, which can be used to synthesize peptides with antigenic activity .

HY-105039

Disomotide G209-2M; GP100:209-217(210M); MPS-22	Peptides	Cancer
Disomotide (G209-2M) is a melanoma antigen that enhances the generation of cytotoxic T lymphocytes (CTL) recognizing native G209 as well as melanoma .

Cat. No.	Product Name

HY-K0221

Affinity Chromatography Column 1 Publications Verification
MCE Affinity Chromatography (AC) Columns are designed for purification of recombinant proteins with different tags, enzymes, antibodies, antigens and nucleic acids.

HY-K2006

Sensitive ECL Kit 2 Publications Verification
Sensitive ECL Kit enables low picogram detection of antigen by oxidizing luminol in the presence of HRP and peroxide. This reaction produces a prolonged chemiluminescence which can be visualized on X-ray film or digital imaging systems.

HY-K2005

High Sensitivity ECL Kit 3 Publications Verification
High Sensitivity ECL Kit enables low picogram detection of antigen by oxidizing luminol in the presence of HRP and peroxide. This reaction produces a prolonged chemiluminescence which can be visualized on X-ray film or digital imaging systems.

HY-K0226

CHO Magnetic Beads (200 nm, 10 mg/mL)
MCE CHO Magnetic Beads (200 nm, 10 mg/mL) contain CHO functional groups, which react with primary amines on proteins or other molecules to form stable amide linkages，can covalently immobilize proteins for the affinity purification of antibodies, antigens and other biomolecules.

HY-K0227

NHS Magnetic Beads (200nm, 10 mg/mL)
MCE NHS Magnetic Beads (200 nm, 10 mg/mL) contain N-hydroxysuccinimide (NHS) functional groups, which react with primary amines on proteins or other molecules to form stable amide linkages，can covalently immobilize proteins for the affinity purification of antibodies, antigens and other biomolecules.

Cat. No.	Product Name	Target	Research Area

HY-P99968

Clivatuzumab	Mucin	Cancer
Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers .

HY-P99624

Foravirumab CR4098	RABV	Infection
Foravirumab (CR4098) is a monoclonal antibody against rabies virus glycoprotein antigenic site III .

HY-P99352

Anetumab Anti-MSLN Antibody	Mesothelin	Cancer
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor .

HY-P9957

Raxibacumab ABthrax	Bacterial	Infection
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .

HY-P3239

Belantamab mafodotin GSK2857916; Belantamab mafodotin-blm	Antibody-Drug Conjugates (ADCs)	Cancer
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity .

HY-P99484

Botensilimab AGEN 1181	CTLA-4	Cancer
Botensilimab (AGEN 1181), a human anti-cytotoxic *T-lymphocyte antigen* 4 (CTLA-4)** monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer .

HY-P99498

Cergutuzumab amunaleukin CEA-IL2v; RG 7813; RO 6895882	Interleukin Related	Inflammation/Immunology Cancer
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .

HY-P99429

Alefacept BG 9273; Human LFA 3IgG fusion protein; LFA 3TIP	Inhibitory Antibodies	Others
Alefacept (BG 9273) is a human lymphocyte function-associated antigen 3/immunoglobulin 1 fusion protein. Alefacept can be used for the research of chronic plaque psoriasis .

HY-P990174

Anti-Mouse Pan-endothelial Cell Antigen/MECA-32 Antibody (MECA-32)	Inhibitory Antibodies	Others
Anti-Mouse Pan-endothelial Cell Antigen/MECA-32 Antibody (MECA-32) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse Pan-endothelial Cell Antigen/MECA-32.

HY-P99541

Tuvirumab anti-hepatitis B; OST 577; SDZ-OST 577	HBV	Infection
Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against *HBV surface antigen* (HBsAg)**. Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research .

HY-P99338

Tisagenlecleucel CTL019	CD19	Inflammation/Immunology Cancer
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma .

HY-P9932

Obiltoxaximab ETI 204	Bacterial	Infection Cardiovascular Disease
Obiltoxaximab (ETI 204) is the second and potent anti-protective antigen (PA) monoclonal antibody with immunogenicity. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication, promoting survival, and inhibiting bacterial spread to the periphery in animal models. Obiltoxaximab can be used in the research of inhalational anthrax, bacteremia and toxemia .

HY-P9918

Tremelimumab Ticilimumab; CP-675206	CTLA-4	Inflammation/Immunology Cancer
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research .

HY-P99760

Nurulimab BCD-145	CTLA-4	Cancer
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma .

HY-P99524

Vatelizumab GBR500	Inhibitory Antibodies	Inflammation/Immunology
Vatelizumab (GBR500) is a monoclonal antibody targeting the *α2 subunit (CD49b) of very late antigen-2 (VLA-2)*. Vatelizumab can be used for the research of multiple sclerosis .

HY-P9942

Sulesomab	Inhibitory Antibodies	Inflammation/Immunology
Sulesomab (IMMU-MN3) is a murine monoclonal antibody fragment of the IgG1 class that binds to Normal Cross-Reactive Antigen-90 present on leukocytes. Sulesomab is cleared into infection nonspecifically through increased capillary membrane permeability .

HY-P990056

Oberotatug	Inhibitory Antibodies	Inflammation/Immunology
Oberotatug is a human IgG1κ antibody targeting the lymphocyte antigen LY75 .

HY-P990054

Eramkafusp Alfa	CD20	Cancer
Eramkafusp Alfa is a human IgG1 antibody targeting the mouse B lymphocyte CD20 antigen MS4A1 .

HY-P99160

Labetuzumab	Inhibitory Antibodies	Cancer
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy .

HY-P99326

Tositumomab Anti-Human CD20 Recombinant Antibody	Radionuclide-Drug Conjugates (RDCs) CD20	Cancer
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes .

HY-P99554

Topsalysin PRX-302	Inhibitory Antibodies	Cancer
Topsalysin is a PSA-activated protoxin, a pore-forming protein (synthetic proaerolysin) fusion protein with human prostate-specific antigen. Topsalysin has tumor suppression effect in mice modle .

HY-P9992

Pelgifatamab BAY-2315497; PSMA-TTC	Inhibitory Antibodies	Inflammation/Immunology
Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody. Pelgifatamab can be covalently linked to a binding moiety of ²²⁵Ac and used for metastatic castration-resistant prostate cancer (mCRPC) research .

HY-P99442

Apolizumab Hu1D10	Apoptosis	Inflammation/Immunology Cancer
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro .

HY-P9901

Ipilimumab 4 Publications Verification MDX-010; BMS-734016	CTLA-4	Cancer
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies .

HY-P99538

Ublituximab LFB-R603; TG-1101; TGTX-1101	CD20	Cancer
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .

HY-P99958

Vixtimotamab AMV-564; TandAb T564	Transmembrane Glycoprotein Inhibitory Antibodies	Cancer
Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem diabody (TandAb) that targets human CD33 and human CD3 antigens. Vixtimotamab can be used for the research of acute myeloid leukemia (AML) .

HY-P99230

Pinatuzumab	Integrin CD22	Cancer
Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL) .

HY-P99834

Crefmirlimab 89Zr-Df-IAB22M2C	Fluorescent Dye	Cancer
Crefmirlimab (89Zr-Df-IAB22M2C) is an anti-human CD8 probe targeting CD8 antigen, which can be used in the diagnosis of various cancers .

HY-P99328

Tucotuzumab Anti-EPCAM Recombinant Antibody; huKS-IL2	Interleukin Related	Inflammation/Immunology Cancer
Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule .

HY-P9953

Certolizumab pegol Certolizumab; CDP870	TNF Receptor	Inflammation/Immunology Cancer
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research .

HY-P99967

Cantuzumab	ADC Antibody	Cancer
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493) .

HY-P99254

Racotumomab 1E10	Inhibitory Antibodies	Inflammation/Immunology Cancer
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in tumors. Racotumomab is an active anticancer agent for lung cancer .

HY-P99049

Sotigalimab	Inhibitory Antibodies	Inflammation/Immunology Cancer
Sotigalimab, a CD40 agonistic monoclonal antibody. Sotigalimab binds CD40 with high affinity and activates antigen-presenting cells, thereby stimulating cancer-specific T cell responses. Sotigalimab is mainly used in the study of metastatic pancreatic cancer and metastatic melanoma .

HY-P99418

Acapatamab AMG-160	Inhibitory Antibodies	Inflammation/Immunology
Acapatamab (AMG-160) is an anti-CD3E/FOLH1 monoclonal antibody .

HY-P99621

Fiztasovimab NPC-21; EV2038	CMV	Infection
Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV .

HY-P99513

Zamerovimab CTB011; SYN023	RABV	Infection
Zamerovimab (CTB011; SYN023) is a mixture of human monoclonal antibodies consisting of CTB011 and CTB012. Zamerovimab binds to non-overlapping epitopes on rabies virus (RABV) glycoprotein, where CTB011 binds to antigenic site III. Zamerovimab can be used in rabies studies .

HY-P9998

Semzuvolimab UB421	HIV	Cancer
Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection .

HY-P99233

Camidanlumab HuMax-TAC	Interleukin Related	Cancer
Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia .

HY-P99933

Eftilagimod alfa IMP321; LAG-3Ig	LAG-3	Cancer
Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research .

HY-P99436

Anatumomab mafenatox ABR-214936	Inhibitory Antibodies	Cardiovascular Disease Inflammation/Immunology Cancer
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness .

HY-P99798

Pacanalotamab AMG 420; BI-836909	CD3	Cancer
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3E. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines .

HY-P99011

Cibisatamab	CD3	Cancer
Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research .

HY-P99276

Abagovomab Anti-Human CA-125 Recombinant Antibody	Inhibitory Antibodies	Cancer
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc) .

HY-P99293

Galiximab IDEC 114; Anti-Human CD80 Recombinant Antibody	CD28	Cancer
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen and blocks CD80–CD28 binding. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma .

HY-P990785

ABBV-383 TNB 383B; Etentamig	CD3	Cardiovascular Disease Inflammation/Immunology Cancer
ABBV-383 (ABBV-383) is a BCMA × CD3 bispecific T-cell engager (BiTE) that can inhibit the activity of B-cell maturation antigen (BCMA) and activate the T-cell surface glycoprotein CD3 complex. ABBV-383 can be used for research in multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases .

HY-P99843

Datopotamab	TROP2 ADC Antibody	Cancer
Datopotamab (CDP7657) is a humanized anti trophoblast cell surface antigen 2 (TROP2) antibody. Datopotamab can generate antibody drug conjugates (ADC) (HY-141598) with DNA topoisomerase I inhibitor Deruxtecan (HY-13631E). Datopotamab can be used in the study of triple negative breast cancer and non-small cell lung cancer .

HY-P99023

Girentuximab G250; cG250	Carbonic Anhydrase	Cancer
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) .

HY-P99464

Bectumomab IMMU-LL 2	CD22	Cancer
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT) .

HY-P99814

Pavurutamab AMG-701	CD3	Inflammation/Immunology Cancer
Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab (HY-P99798). The Fc of Pavurutamab is coupled to molecules to improve pharmacokinetic parameters. Pavurutamab has potential applications in immune regulation and multiple myeloma (MM) .

HY-P99742

Mitazalimab ADC-1013; JNJ-64457107	TNF Receptor	Cancer
Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment .

Species:	Human (439) Virus (5) Marmoset (1) Rhesus Macaque/Cynomolgus (1) Rhesus Macaque (38) Mouse (144) Rat (60) Cynomolgus (65) Rabbit (3) Dog (1) Canine (8) Pig (3)
Tag:	His (528) SUMO (32) Tag Free (30) Strep (2) Avi (91) Myc (11) GST (14) MBP (1) Trx (3) Fc (195) B2M (3) Flag (6)
Source:	HEK293 (586) E. coli Cell-free (5) CHO (2) CHO (2) P. pastoris (22) Sf9 insect cells (23) E. coli (118)

Cat. No.	Compare	Product Name	Species	Source

HY-P75356

	CEACAM5 Protein, Human (HEK293, His, solution) Carcinoembryonic Antigen; CEA; Meconium Antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (HEK293, His, solution) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P72362

	CEACAM5 Protein, Human (Biotinylated, HEK293, His-Avi) Carcinoembryonic Antigen; CEA; Meconium Antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-Avi, C-6*His labeled tag. The total length of CEACAM5 Protein, Human (Biotinylated, HEK293, His-Avi) is 651 a.a., with molecular weight of 110-150 kDa.

HY-P70223

	*Lymphocyte antigen* 86/LY86 Protein, Human (HEK293, Fc)** rHuLymphocyte Antigen 86/MD-1, Fc; Lymphocyte Antigen 86; LY86; MD1; Protein MD-1	Human	HEK293
	Lymphocyte antigen 86/LY86 acts synergistically with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and influence cytokine production. It plays a crucial role in promoting the high expression of CD180 on the cell surface, forming an M-shaped tetramer with two CD180-LY86 heterodimers. Lymphocyte antigen 86/LY86 Protein, Human (HEK293, Fc) is the recombinant human-derived Lymphocyte antigen 86/LY86 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Lymphocyte antigen 86/LY86 Protein, Human (HEK293, Fc) is 142 a.a., with molecular weight of 45-55 kDa.

HY-P71803

	*26 kDa secreted antigen/TES-26 Protein, Canine (P.pastoris, His)* TES-2626kDa secreted Antigen; Toxocara excretory-secretory Antigen 26; TES-26	Canine	P. pastoris
	26 kDa secreted antigen/TES-26 Protein, Canine (P.pastoris, His) is a recombinant canine 26 kDa secreted antigen/TES-26 Protein expressed in P.pastoris with a His tag at the N-terminus. Recombinant TES-26 is a potential diagnostic candidate antigen for human toxocarosis caused by migrating T. canis larvae.

HY-P76817

	CEACAM5 Protein, Cynomolgus (HEK293, His) Carcinoembryonic Antigen; CEA; Meconium Antigen 100; CD66e	Cynomolgus	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag. The total length of CEACAM5 Protein, Cynomolgus (HEK293, His) is 688 a.a., with molecular weight of 105-140 kDa.

HY-P77181

	RP105/CD180 Protein, Human (HEK293, His) CD180 Antigen; Lymphocyte Antigen 64; LY64	Human	HEK293
	RP105/CD180 is a key mediator in B cells that cooperates with MD-1 and TLR4 to initiate the innate immune response against bacterial lipopolysaccharide (LPS). This cooperation activates NF-kappa-B, underscoring its role in key signaling pathways. RP105/CD180 Protein, Human (HEK293, His) is the recombinant human-derived RP105/CD180 protein, expressed by HEK293 , with C-His labeled tag.

HY-P77182

	RP105/CD180 Protein, Mouse (HEK293, Fc) CD180 Antigen; Lymphocyte Antigen 64; LY64	Mouse	HEK293
	The RP105/CD180 protein is a key mediator in the B cell innate immune response to bacterial lipopolysaccharide (LPS), possibly synergizing with MD-1 and TLR4.Its participation activates NF-kappa-B and initiates immune signaling pathways.RP105/CD180 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived RP105/CD180 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P77183

	RP105/CD180 Protein, Mouse (HEK293, His) CD180 Antigen; Lymphocyte Antigen 64; LY64	Mouse	HEK293
	The RP105/CD180 protein is a key mediator in the B cell innate immune response to bacterial lipopolysaccharide (LPS), possibly synergizing with MD-1 and TLR4.Its participation activates NF-kappa-B and initiates immune signaling pathways. RP105/CD180 Protein, Mouse (HEK293, His) is the recombinant mouse-derived RP105/CD180 protein, expressed by HEK293 , with C-His labeled tag.

HY-P71830

	*Lymphocyte antigen* 6E/LY6E Protein, Mouse (P.pastoris, His, SUMO)** Ly6e; Ly67; Sca-2; Tsa-1Lymphocyte Antigen 6E; Ly-6E; Stem cell Antigen 2; Thymic shared Antigen 1; TSA-1	Mouse	P. pastoris
	LY6E is a GPI-anchored cell surface protein that regulates T lymphocyte function by binding to CD3Z/CD247, affecting proliferation, differentiation and activation.It modulates T cell receptor signaling and exhibits antiviral activity against mouse hepatitis virus.Lymphocyte antigen 6E/LY6E Protein, Mouse (P.pastoris, His, SUMO) is the recombinant mouse-derived Lymphocyte antigen 6E/LY6E protein, expressed by P.pastoris , with N-His, N-SUMO labeled tag.

HY-P75355

	CEACAM5 Protein, Human (Biotinylated, HEK293, C-His) Carcinoembryonic Antigen; CEA; Meconium Antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (Biotinylated, HEK293, C-His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with N-His, N-GST labeled tag. The total length of CEACAM5 Protein, Human (Biotinylated, HEK293, C-His) is 651 a.a., with molecular weight of 100-110 kDa.

HY-P70675

	CEACAM5 Protein, Human (HEK293, His) 1 Publications Verification Carcinoembryonic Antigen-related cell adhesion molecule 5; Carcinoembryonic Antigen; CEA; Meconium Antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (HEK293, His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of CEACAM5 Protein, Human (HEK293, His) is 651 a.a., with molecular weight of 110-150 kDa.

HY-P75392

	CD58 Protein, Human (HEK293, Fc) Lymphocyte Function-Associated Antigen 3; LFA3; Ag3; CD58 Antigen	Human	HEK293
	CD58 Protein, Human (HEK293, Fc) is the recombinant human-derived CD58 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CD58 Protein, Human (HEK293, Fc) is 187 a.a., with molecular weight of ~68 kDa.

HY-P70505

	CD19 Protein, Human (HEK293, Fc) B-Lymphocyte Antigen CD19; B-Lymphocyte Surface Antigen B4; Differentiation Antigen CD19; T-Cell Surface Antigen Leu-12; CD19	Human	HEK293
	The CD19 protein is a B cell antigen receptor coreceptor that enhances downstream signaling pathways, lowers the activation threshold, and helps B cells respond to antigens. It activates phosphatidylinositol 3-kinase and mobilizes intracellular Ca(2+). CD19 Protein, Human (HEK293, Fc) is the recombinant human-derived CD19 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CD19 Protein, Human (HEK293, Fc) is 272 a.a., with molecular weight of ~85.0 kDa.

HY-P75468

	BST2 Protein, Mouse (HEK293, His) Bone marrow stromal Antigen 2; BST-2; HM1.24 Antigen; Bst2	Mouse	HEK293
	The BST2 protein is an IFN-induced antiviral factor that inhibits mammalian enveloped viruses by tethering viral particles to infected cell membranes. BST2 acts as a physical tether connecting virions, limiting their release and spread. BST2 Protein, Mouse (HEK293, His) is the recombinant mouse-derived BST2 protein, expressed by HEK293 , with N-His labeled tag. The total length of BST2 Protein, Mouse (HEK293, His) is 100 a.a., with molecular weight of ~13.6-24 kDa.

HY-P75469

	BST2 Protein, Mouse (HEK293, hFc) Bone marrow stromal Antigen 2; BST-2; HM1.24 Antigen; Bst2	Mouse	HEK293
	The BST2 protein is an IFN-induced antiviral factor that inhibits mammalian enveloped viruses by tethering viral particles to infected cell membranes. BST2 acts as a physical tether connecting virions, limiting their release and spread. BST2 Protein, Mouse (HEK293, hFc) is the recombinant mouse-derived BST2 protein, expressed by HEK293 , with N-hFc labeled tag. The total length of BST2 Protein, Mouse (HEK293, hFc) is 100 a.a., with molecular weight of 4-50 kDa.

HY-P71562

	CT83 Protein, Human (His, B2M) 1 Publications Verification CT83; CXorf61; KKLC1; Kita-kyushu lung cancer Antigen 1; KK-LC-1; Cancer/testis Antigen 83	Human	E. coli
	The CT83 protein shows specific expression in the testis, highlighting its selective presence in this reproductive organ. In addition, multiple cancer cell lines express CT83, suggesting a potential association with malignancy. CT83 Protein, Human (His, B2M) is the recombinant human-derived CT83 protein, expressed by E. coli , with N-His, B2M labeled tag.

HY-P71758

	CD20/MS4A1 Protein, Mouse (P.pastoris, His) Ms4a1; Cd20; Ly-44; Ms4a2; B-lymphocyte Antigen CD20; B-cell differentiation Antigen Ly-44; Lymphocyte Antigen 44; CD Antigen	Mouse	P. pastoris
	CD20/MS4A1 protein regulates cellular calcium influx, essential for B-lymphocyte development, differentiation, and activation. It activates store-operated calcium channels, allowing calcium influx through B-cell receptor/BCR activation. CD20/MS4A1 protein forms homotetramers and interacts with cell surface IgM chains, the antigen-binding parts of the BCR. CD20/MS4A1 Protein, Mouse (P.pastoris, His) is the recombinant mouse-derived CD20/MS4A1 protein, expressed by P. pastoris , with N-6*His labeled tag. The total length of CD20/MS4A1 Protein, Mouse (P.pastoris, His) is 181 a.a., with molecular weight (glycosylation form) of ~33 kDa.

HY-P72124

	CD63 Protein, Mouse (GST) Cd63CD63 Antigen; CD Antigen CD63	Mouse	E. coli
	The CD63 protein is an important cell surface receptor that activates multiple signaling cascades. It plays a role in integrin signaling, leading to activation of AKT, FAK/PTK2, and MAP kinases. CD63 Protein, Mouse (GST) is the recombinant mouse-derived CD63 protein, expressed by E. coli , with N-GST labeled tag. The total length of CD63 Protein, Mouse (GST) is 101 a.a., with molecular weight of ~38.5 kDa.

HY-P71539

	*Lymphocyte antigen* 6E/LY6E Protein, Human (His-SUMO)** LY6E; 9804; RIGE; SCA2; TSA1; Lymphocyte Antigen 6E; Ly-6E; Retinoic acid-induced gene E protein; RIG-E; Stem cell Antigen 2; SCA-2; Thymic shared Antigen 1; TSA-1	Human	E. coli
	Lymphocyte antigen 6E/LY6E protein is a GPI-anchored cell surface regulator that regulates T cell receptor signaling through interaction with CD3Z/CD247. It limits the entry of human coronaviruses, serves as the primary receptor for syncytin-A, and may modulate nicotinic acetylcholine receptor activity. Lymphocyte antigen 6E/LY6E Protein, Human (His-SUMO) is the recombinant human-derived Lymphocyte antigen 6E/LY6E protein, expressed by E. coli , with N-His, N-SUMO labeled tag.

HY-P71817

	UAP1 Protein, Human (P.pastoris, His) AGX 1; AGX-2; AGX1; Antigen X; AntigenX; SPAG 2; SPAG2; Sperm associated Antigen 2; Sperm-associated Antigen 2; UAP 1; uap1	Human	P. pastoris
	UAP1 protein functions as an enzyme that catalyzes the conversion of UTP and GlcNAc-1-P into UDP-GlcNAc, as well as UTP and GalNAc-1-P into UDP-GalNAc. Notably, isoform AGX1 exhibits 2 to 3 times higher activity towards GalNAc-1-P, while isoform AGX2 displays 8 times more activity towards GlcNAc-1-P, highlighting distinct substrate preferences between the isoforms. UAP1 Protein, Human (P.pastoris, His) is the recombinant human-derived UAP1 protein, expressed by P. pastoris , with N-His labeled tag. The total length of UAP1 Protein, Human (P.pastoris, His) is 522 a.a., with molecular weight of ~60.8 kDa.

HY-P700444

	CD20/MS4A1 Protein-VLP, Dog (HEK293, His) Ms4a1; Cd20; Ly-44; Ms4a2; B-lymphocyte Antigen CD20; B-cell differentiation Antigen Ly-44; Lymphocyte Antigen 44; CD Antigen	Dog	HEK293
	CD20/MS4A1 Protein-VLP, Dog (HEK293, His) is recommended for animal immunization, ELISA. It is not recommended for receptor-ligand interaction detection and SPR/BLI assay since there are other irrelevant membrane proteins of the host on the VLP envelope, and the receptor-ligand interaction will have strong background interference. High requirements for chips and experimental protocols are needed for SPR/BLI assays. If VLP control is required, it is recommended HY-P701236. Tags can only be detected under denaturing conditions.

HY-P700471

	CEACAM6 Protein, Human (HEK293, His) carcinoembryonic Antigen-related cell adhesion molecule 6 (non-specific cross reacting Antigen); NCA; carcinoembryonic Antigen-related cell adhesion molecule 6; CD66c; normal cross-reacting Antigen; non-specific crossreacting Antigen; CEAL	Human	HEK293
	The CEACAM6 protein is a cell surface glycoprotein that promotes calcium- and fibronectin-independent cell-cell adhesion and mediates homo- and heterosexual interactions with other carcinoembryonic antigen-related cell adhesion molecules. CEACAM6 Protein, Human (HEK293, His) is the recombinant human-derived CEACAM6 protein, expressed by HEK293 , with C-10*His labeled tag.

HY-P74441

	*Lymphocyte antigen* 86/MD-1 Protein, Mouse (HEK293, His)** LY86; lymphocyte Antigen 86; MD-1; MMD-1; RP105-associated	Mouse	HEK293
	Lymphocyte antigen 86/MD-1 acts synergistically with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and influence cytokine production.It plays a crucial role in promoting the high expression of CD180 on the cell surface, forming an M-shaped tetramer with two CD180-LY86 heterodimers.Lymphocyte antigen 86/MD-1 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Lymphocyte antigen 86/MD-1 protein, expressed by HEK293 , with C-His labeled tag.

HY-P72131

	CEACAM6 Protein, Human (His-SUMO) Carcinoembryonic Antigen related cell adhesion molecule 6 ; Carcinoembryonic Antigen related cell adhesion molecule 6 non specific cross reacting Antigen; ; Carcinoembryonic Antigen-related cell adhesion molecule 6; CD 66c; CD66c; CD66c Antigen; CEA LIKE PROTEIN; CEACAM 6; CEACAM6; CEAL; CEAM6_HUMAN; MGC93832; NCA; Non specific cross reacting Antigen; Non-specific crossreacting Antigen; Normal cross reacting Antigen; Normal cross-reacting Antigen	Human	E. coli
	The CEACAM6 protein is a cell surface glycoprotein that promotes calcium- and fibronectin-independent cell-cell adhesion and mediates homo- and heterosexual interactions with other carcinoembryonic antigen-related cell adhesion molecules. CEACAM6 Protein, Human (His-SUMO) is the recombinant human-derived CEACAM6 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag. The total length of CEACAM6 Protein, Human (His-SUMO) is 286 a.a., with molecular weight of ~47.2 kDa.

HY-P75433

	CD20/MS4A1 Protein, Cynomolgus (85a.a, HEK293, His) Ms4a1; Cd20; Ly-44; Ms4a2; B-lymphocyte Antigen CD20; B-cell differentiation Antigen Ly-44; Lymphocyte Antigen 44; CD Antigen	Cynomolgus	HEK293
	CD20/MS4A1 protein is a B lymphocyte membrane protein that plays a crucial regulatory role in cellular calcium influx, which is essential for the development, differentiation and activation of B lymphocytes. As part of a store-operated calcium (SOC) channel, it promotes calcium influx upon B cell receptor/BCR activation. CD20/MS4A1 Protein, Cynomolgus (85a.a, HEK293, His) is the recombinant cynomolgus-derived CD20/MS4A1 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD20/MS4A1 Protein, Cynomolgus (85a.a, HEK293, His) is 85 a.a., with molecular weight of 22.66 & 24.28 kDa, respectively.

HY-P76808

	CD58 Protein, Cynomolgus (HEK293, His) Lymphocyte Function-Associated Antigen 3; Surface Glycoprotein LFA-3; LFA3; Ag3; CD58 Antigen	Cynomolgus	HEK293
	ANGPTL7/angiopoietin-related 7 protein plays a crucial role in the formation and organization of the extracellular matrix. Particularly in the eye, it serves as a mediator for dexamethasone-induced matrix deposition within the trabecular meshwork, a tissue that studies have shown is necessary for aqueous humor outflow and maintenance of intraocular pressure. CD58 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CD58 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD58 Protein, Cynomolgus (HEK293, His) is 215 a.a., with molecular weight of 38-42 kDa.

HY-P74441A

	*Lymphocyte antigen* 86/MD-1 Protein, Mouse (HEK293, C-6His)* LY86; lymphocyte Antigen 86; MD-1; MMD-1; RP105-associated	Mouse	HEK293

HY-P700420

	MAGEA4 Protein, Human (HEK293, His) MAGEA4; melanoma Antigen family A, 4; MAGE4; melanoma-associated Antigen 4; cancer/testis Antigen family 1; member 4; CT1.4; MAGE 41; MAGE X2; MAGE4A; MAGE4B; melanoma associated Antigen 4; MGC21336	Human	HEK293
	MAGEA4 protein critically regulates cell proliferation by inhibiting G1 phase arrest and negatively modulates p53-mediated apoptosis. Its role in controlling key checkpoints emphasizes its impact on cellular homeostasis, suggesting significance in averting aberrant cell growth. MAGEA4 Protein, Human (HEK293, His) is the recombinant human-derived MAGEA4 protein, expressed by HEK293, with C-10*His labeled tag. The total length of MAGEA4 Protein, Human (HEK293, His) is 317 a.a., with molecular weight of 36.7 kDa.

HY-P700441

	DNAM-1 Protein, Human (HEK293, hFc, Myc) CD226; CD226 molecule; CD226 Antigen; DNAM 1; DNAM1; PTA1; TLiSA1; adhesion glycoprotein; DNAX accessory molecule 1; DNAX accessory molecule-1; platelet and T cell activation Antigen 1; T lineage-specific activation Antigen 1 Antigen; DNAM-1	Human	HEK293
	DNAM-1 protein is a key player in cell-cell adhesion and lymphocyte signaling, mediating cytotoxicity and lymphokine secretion of CTL and NK cells. As a receptor for NECTIN2, DNAM-1 stimulates T cell proliferation and cytokine production (IL2, IL5, IL10, IL13, and IFNG) upon ligand binding. DNAM-1 Protein, Human (HEK293, hFc, Myc) is the recombinant human-derived DNAM-1 protein, expressed by HEK293 , with C-Myc, C-hFc labeled tag. The total length of DNAM-1 Protein, Human (HEK293, hFc, Myc) is 229 a.a., with molecular weight of 56.1 kDa.

HY-P72720

	CD58 Protein, Human (HEK293, His) 1 Publications Verification Lymphocyte Function-Associated Antigen 3; Surface Glycoprotein LFA-3; CD58; LFA3; Ag3; CD58 Antigen	Human	HEK293
	CD58, a glycoprotein, is also known as lymphocyte-function antigen 3 (LFA-3). CD58 is a costimulatory receptor, and can interact with its natural ligand (CD2, primarily expressed on the surface of T/NK cells). The CD2-CD58 interaction can promote cell adhesion and recognition, and regulate antiviral responses, inflammatory responses in autoimmune diseases, immune rejection of transplantation, and immune evasion of tumor cells. CD58 Protein, Human (HEK293, His) is the recombinant human-derived CD58 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of CD58 Protein, Human (HEK293, His) is 187 a.a., with molecular weight of 30-60 kDa.

HY-P7833

	CD19 Protein, Cynomolgus/Rhesus Macaque (HEK293, Fc) rRhCD19 molecule/CD19, Fc; B-Lymphocyte Antigen CD19; B-Lymphocyte Surface Antigen B4; Differentiation Antigen CD19; T-Cell Surface Antigen Leu-12; CD19	Rhesus Macaque	HEK293
	CD19 is a signaling component of the B-cell receptor complex that lowers the threshold for antigen-driven activation. CD19 Protein, Cynomolgus/Rhesus Macaque (HEK293, Fc) is the recombinant Rhesus Macaque-derived CD19 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P703688

	CD2/SRBC Protein, Mouse (HEK293, His) T-cell surface Antigen CD2; LFA-2; LFA-3 receptor; Lymphocyte Antigen 37; Ly-37; T-cell surface Antigen T11/Leu-5; Cd2; Ly-37	Mouse	HEK293

HY-P70497

	CD7 Protein, Human (HEK293, His) T-Cell Antigen CD7; GP40; T-Cell Leukemia Antigen; T-Cell Surface Antigen Leu-9; TP41; CD7	Human	HEK293
	CD7 Protein, with an elusive function, interacts with SECTM1, implying involvement in SECTM1-related cellular processes. Further research is essential to uncover the specific functions and molecular pathways in which CD7 intricately participates. The current lack of detailed information emphasizes the ongoing exploration needed to elucidate CD7's functional significance and its interplay with SECTM1 in cellular contexts. CD7 Protein, Human (HEK293, His) is the recombinant human-derived CD7 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of CD7 Protein, Human (HEK293, His) is 155 a.a., with molecular weight of ~32.0 kDa.

HY-P72361

	CD7 Protein, Human (Biotinylated, HEK293, His-Avi) T-Cell Antigen CD7; GP40; T-Cell Leukemia Antigen; T-Cell Surface Antigen Leu-9; TP41	Human	HEK293
	CD7 Protein, with an elusive function, interacts with SECTM1, implying involvement in SECTM1-related cellular processes. Further research is essential to uncover the specific functions and molecular pathways in which CD7 intricately participates. The current lack of detailed information emphasizes the ongoing exploration needed to elucidate CD7's functional significance and its interplay with SECTM1 in cellular contexts. CD7 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CD7 protein, expressed by HEK293 , with C-Avi, C-6*His labeled tag. The total length of CD7 Protein, Human (Biotinylated, HEK293, His-Avi) is 155 a.a., with molecular weight of 30-35 kDa.

HY-P72128

	CEACAM1 Protein, Human (His-SUMO) Antigen CD66; BGP 1; BGP; BGP-1; BGPI; Biliary glycoprotein 1; Biliary glycoprotein adhesion molecule; Biliary glycoprotein; Carcinoembryonic Antigen related cell adhesion molecule 1; carcinoembryonic Antigen-related cell adhesion molecule 1 biliary glycoprotein; ; Carcinoembryonic Antigen-related cell adhesion molecule 1; CD66a; CD66a Antigen; CEACAM1; CEAM1_HUMAN; meconium Antigen 100	Human	E. coli
	CEACAM1 protein is involved in various biological processes. It is phosphorylated by the insulin receptor (INSR) in response to insulin stimulation, thereby promoting insulin clearance and regulating hepatic lipogenesis. CEACAM1 Protein, Human (His-SUMO) is the recombinant human-derived CEACAM1 protein, expressed by E. coli , with N-10*His, N-SUMO labeled tag. The total length of CEACAM1 Protein, Human (His-SUMO) is 394 a.a., with molecular weight of ~63.3 kDa.

HY-P72129

	CEACAM1 Protein, Human Antigen CD66; BGP 1; BGP; BGP-1; BGPI; Biliary glycoprotein 1; Biliary glycoprotein adhesion molecule; Biliary glycoprotein; Carcinoembryonic Antigen related cell adhesion molecule 1; carcinoembryonic Antigen-related cell adhesion molecule 1 biliary glycoprotein; ; Carcinoembryonic Antigen-related cell adhesion molecule 1; CD66a; CD66a Antigen; CEACAM1; CEAM1_HUMAN; meconium Antigen 100	Human	E. coli
	CEACAM1 protein is involved in various biological processes. It is phosphorylated by the insulin receptor (INSR) in response to insulin stimulation, thereby promoting insulin clearance and regulating hepatic lipogenesis. CEACAM1 Protein, Human is the recombinant human-derived CEACAM1 protein, expressed by E. coli , with tag free. The total length of CEACAM1 Protein, Human is 394 a.a., with molecular weight of ~43.3 kDa.

HY-P72129A

	CEACAM1 Protein, Human (N-His) Antigen CD66; BGP 1; BGP; BGP-1; BGPI; Biliary glycoprotein 1; Biliary glycoprotein adhesion molecule; Biliary glycoprotein; Carcinoembryonic Antigen related cell adhesion molecule 1; carcinoembryonic Antigen-related cell adhesion molecule 1 biliary glycoprotein; ; Carcinoembryonic Antigen-related cell adhesion molecule 1; CD66a; CD66a Antigen; CEACAM1; CEAM1_HUMAN; meconium Antigen 100	Human	E. coli
	CEACAM1 protein is involved in various biological processes. It is phosphorylated by the insulin receptor (INSR) in response to insulin stimulation, thereby promoting insulin clearance and regulating hepatic lipogenesis. CEACAM1 Protein, Human (N-His) is the recombinant human-derived CEACAM1 protein, expressed by E. coli , with N-6*His labeled tag. The total length of CEACAM1 Protein, Human (N-His) is 394 a.a., with molecular weight of ~45 kDa.

HY-P71757

	MME Protein, Human (P.pastoris, His) Atriopeptidase; CALLA; CD10; CD10 Antigen; Common acute lymphocytic leukemia Antigen	Human	P. pastoris
	MME proteins exhibit thermolysin-like specificity and primarily degrade polypeptides of up to 30 amino acids. Crucially, it plays a key role in cleaving the Gly-Phe bond to degrade opioid peptides, including Met-enkephalin and Leu-enkephalin. MME Protein, Human (P.pastoris, His) is the recombinant human-derived MME protein, expressed by P. pastoris , with N-His labeled tag. The total length of MME Protein, Human (P.pastoris, His) is 699 a.a., with molecular weight of ~81.8 kDa.

HY-P77081

	MD-2/LY96 Protein, Mouse (HEK293, Fc) Lymphocyte Antigen 96; Ly-96; ESOP-1	Mouse	HEK293
	MD-2/LY96 Protein, acting as a monomer, robustly and specifically binds to interleukin-13 (IL13), distinguishing it from interleukin-4 (IL4) with which it does not interact.This selective binding highlights MD-2/LY96's pivotal role in mediating cellular responses to IL13, underscoring its significance in IL13-related biological activities.MD-2/LY96 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived MD-2/LY96 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P78756

	CEACAM5 Protein, Mouse (HEK293, His) CEACAM-5; CD66e; CEA; Meconium Antigen 100	Mouse	HEK293
	The CEACAM5 protein is a key cell surface glycoprotein that promotes cell adhesion, signaling, and tumor progression. It interacts with CEACAM6 and other related molecules to support homo- and hetero-sex adhesion. CEACAM5 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P700104AF

	Animal-Free IL-17A Protein, Human (His) Cytotoxic T-lymphocyte-associated Antigen 8; CTLA-8	Human	E. coli
	The IL-17A protein is an important effector cytokine that is critical in both innate and adaptive immunity to defend against microorganisms and maintain tissue integrity. It acts through the IL17RA-IL17RC heterodimeric receptor complex, triggering signaling pathways, activating immune-related gene transcription and promoting strong immune inflammation. Animal-Free IL-17A Protein, Human (His) is the recombinant human-derived animal-FreeIL-17A protein, expressed by E. coli , with C-His labeled tag. The total length of Animal-Free IL-17A Protein, Human (His) is 136 a.a., with molecular weight of ~16.47 kDa.

HY-P701066

	MD2 Protein, Cynomolgus (His) Lymphocyte Antigen 96; LY96; ESOP1; ESOP-1; MD-2	Cynomolgus	E. coli
	MD2 protein binds bacterial lipopolysaccharide (LPS) and collaborates with TLR4 in the innate immune response to LPS. It also interacts with TLR2 in the response to cell wall components from bacteria. MD2 enhances TLR4-dependent NF-kappa-B activation and forms a heterogeneous homomer, participating in a multi-protein complex with CD14 and TLR4. Ligand binding induces complex oligomerization, crucial for the cellular response to LPS. MD2 Protein, Cynomolgus (His) is the recombinant cynomolgus-derived MD2 protein, expressed by E. coli , with C-His labeled tag. The total length of MD2 Protein, Cynomolgus (His) is 142 a.a., with molecular weight of 17.97 kDa.

HY-P72133

	CEACAM8/CD66b Protein, Human (His-SUMO) Carcinoembryonic Antigen CGM6; Carcinoembryonic Antigen gene family member 6; Carcinoembryonic Antigen related cell adhesion molecule 8; Carcinoembryonic Antigen-related cell adhesion molecule 8; CD 66b; CD 67; CD66b; CD66b Antigen; CD67; CD67 Antigen; CEACAM 8; CEACAM8; CEAM8_HUMAN; CGM 6; CGM6; NCA 95; NCA95; Non-specific cross-reacting Antigen NCA-95; Nonspecific cross reacting Antigen NCA 95; Nonspecific cross reacting Antigen NCA95	Human	E. coli
	CEACAM8/CD66b protein is a cell surface glycoprotein that promotes calcium-independent heterophil cell adhesion to other carcinoembryonic antigen-related cell adhesion molecules, particularly CEACAM6, in activated neutrophils Especially obvious. CEACAM8/CD66b Protein, Human (His-SUMO) is the recombinant human-derived CEACAM8/CD66b protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag. The total length of CEACAM8/CD66b Protein, Human (His-SUMO) is 286 a.a., with molecular weight of ~47.5 kDa.

HY-P70217

	*Lymphocyte antigen* 6H/LY6H Protein, Human (HEK293, His)** rHuLymphocyte Antigen 6H/LY6H, His; Lymphocyte Antigen 6H; Ly-6H; LY6H	Human	HEK293
	LY6H mediates the myelin trophic and neurotrophic effects of PSAP/Prosaposin protein through GPR37 and GPR37L1 receptors. Ligand-mediated internalization of these receptors results in ERK phosphorylation signaling. Lymphocyte antigen 6H/LY6H Protein, Human (HEK293, His) is the recombinant human-derived Lymphocyte antigen 6H/LY6H protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Lymphocyte antigen 6H/LY6H Protein, Human (HEK293, His) is 90 a.a., with molecular weight of ~18.0 kDa.

HY-P7673

	BST2 Protein, Human (HEK293, His) rHuBST2, His; Bone Marrow Stromal Antigen 2; BST-2	Human	HEK293
	BST2 Protein, Human (HEK293, His) is a recombinant human bone marrow stromal antigen 2 produced in HEK293 cells. Bone marrow stromal antigen 2 (BST-2; also known as tetherin or CD317) is an IFN-inducible gene that functions to block the release of a range of nascent enveloped virions from infected host cells.

HY-P702582

	LY6D Protein, Human (HEK293, Fc) Ly-6D; lymphocyte Antigen 6 complex; locus D	Human	HEK293

HY-P7036

	IL-17A Protein, Human 1 Publications Verification rHuIL-17; IL-17A; Cytotoxic T-lymphocyte-associated Antigen 8; CTLA-8	Human	E. coli
	IL-17A is a homodimeric cytokine and plays a critical role in host defense mechanisms against many bacterial and fungal pathogens as well as allergic and autoimmune responses. IL-17A induces the production of antimicrobial peptides, cytokines, chemokines, and matrix metalloproteinases. IL-17A Protein, Human is a recombinant human IL-17A protein and is expressed in E. coli. It consists of 137 amino acids (I19-A155).

HY-P74328

	CD19 Protein, Mouse (HEK293, His) B-lymphocyte Antigen CD19; CD19; B-lymphocyte surface Antigen B4	Mouse	HEK293
	The CD19 protein acts as a coreceptor for B cell antigen receptors, lowering the signaling threshold and initiating B cell responses to antigens. It activates a cascade leading to PI3K activation and Ca(2+) mobilization. CD19 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CD19 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD19 Protein, Mouse (HEK293, His) is 271 a.a., with molecular weight of ~51 kDa.

HY-P74330

	CD19 Protein, Human (HEK293, His) B-lymphocyte Antigen CD19; CD19; B-lymphocyte surface Antigen B4	Human	HEK293
	The CD19 protein is a B cell antigen receptor coreceptor that enhances downstream signaling pathways, lowers the activation threshold, and helps B cells respond to antigens. It activates phosphatidylinositol 3-kinase and mobilizes intracellular Ca(2+). CD19 Protein, Human (HEK293, His) is the recombinant human-derived CD19 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD19 Protein, Human (HEK293, His) is 291 a.a., with molecular weight of ~47 kDa.

HY-P701067

	MD2 Protein, Human (His) Lymphocyte Antigen 96; LY96; Ly-96; ESOP1; ESOP-1; MD-2	Human	E. coli
	MD2 protein binds bacterial lipopolysaccharide (LPS) and collaborates with TLR4 in the innate immune response to LPS. It also interacts with TLR2 in the response to cell wall components from bacteria. MD2 enhances TLR4-dependent NF-kappa-B activation and forms a heterogeneous homomer, participating in a multi-protein complex with CD14 and TLR4. Ligand binding induces complex oligomerization, crucial for the cellular response to LPS. MD2 Protein, Human (His) is the recombinant human-derived MD2 protein, expressed by E. coli , with C-His labeled tag. The total length of MD2 Protein, Human (His) is 142 a.a., with molecular weight of 18.07 kDa.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80446

	CD19 Antibody (YA543) CD19_HUMAN; B-lymphocyte Antigen CD19; B-lymphocyte surface Antigen B4; Differentiation Antigen CD19; T-cell surface Antigen Leu-12; CD_Antigen: CD19; B-lymphocyte surface Antigen B4; Leu 12; Leu12	WB, ICC/IF, IHC-P, FC	Human
	CD19 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to CD19. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

HY-P83511

	*SV40 T Antigen* Antibody (YA3256)** Large T Antigen; LT; LT-AG	WB, ICC/IF, IP	Species independent
	SV40 T Antigen Antibody (YA3256) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3256), targeting SV40 T Antigen, with a predicted molecular weight of 82 kDa (observed band size: 90 kDa). SV40 T Antigen Antibody (YA3256) can be used for WB, ICC/IF, IP experiment in species independent background.

HY-P80597

	CD19 Antibody (YA807) CD19; B-lymphocyte Antigen CD19; B-lymphocyte surface Antigen B4; Differentiation Antigen CD19; T-cell surface Antigen Leu-12; CD19	ICC/IF, FC	Human
	CD19 Antibody (YA807) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD19 (3G7). It can be used for ICC/IF,FC assays with tag free, in the background of Human.

HY-P81086

	RAGE Antibody Advanced glycosylation end product specific receptor; Advanced glycosylation end product-specific receptor; AGER; EC 2.7.11.22; LE 9211 A Antigen; LE-9211-A Antigen; MGC22357; MOK; RAGE 1; RAGE1; MOK protein kinase; Receptor for advanced glycation endproducts; Renal tumor Antigen 1; Renal tumor Antigen; Renal cell carcinoma Antigen (MOK protein kinase); Renal tumor Antigen 1; RAGE_HUMAN.	WB, IHC-P, FC	Human, Mouse, Rat,
	RAGE Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-RAGE polyclonal antibody. RAGE Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.

HY-P81234

	Ki-67 Antibody 1 Publications Verification Antigen identified by monoclonal antibody Ki 67; Antigen KI67; KIA; Ki67; MKI67; Proliferation related Ki 67 Antigen; Antigen KI-67; KI67_MOUSE.	IHC-P, IHC-F, ICC/IF	Human
	Ki-67 Antibody is an unconjugated, approximately 358 kDa, rabbit-derived, anti-Ki-67 polyclonal antibody. Ki-67 Antibody can be used for: IHC-P, IHC-F, ICC, IF expriments in human background without labeling.

HY-P81405

	SAGE1 Antibody (YA1150) SAGE; SAGE1; Sarcoma Antigen 1; Cancer/testis Antigen 14 (CT14)	IHC-P	Human
	SAGE1 Antibody (YA1150) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1150), targeting SAGE1. SAGE1 Antibody (YA1150) can be used for IHC-P experiment in human background.

HY-P81360

	MAGEA1 Antibody (YA1105) MAGEA1; MAGE1, MAGE1A; Melanoma-associated Antigen 1; Antigen MZ2-E; Cancer/testis Antigen 1.1 (CT1.1); MAGE-1 Antigen	IHC-P	Human
	MAGEA1 Antibody (YA1105) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1105), targeting MAGEA1. MAGEA1 Antibody (YA1105) can be used for IHC-P experiment in human background.

HY-P81792

	*Prostate Specific Antigen* Antibody (YA1537)** KLK3; APS; Prostate-specific Antigen; PSA; Gamma-seminoprotein; Seminin; Kallikrein-3; P-30 Antigen; Semenogelase	WB, IHC-P	Human
	Prostate Specific Antigen Antibody (YA1537) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1537), targeting Prostate Specific Antigen, with a predicted molecular weight of 29 kDa (observed band size: 34 kDa). Prostate Specific Antigen Antibody (YA1537) can be used for WB, IHC-P experiment in human background.

HY-P81080

	CEA Antibody (YA917) Carcinoembryonic Antigen; Carcinoembryonic Antigen related cell adhesion molecule 5; Carcinoembryonic Antigen-related cell adhesion molecule 5; CD66e; CD66e Antigen; CEACAM5; CEAM5_HUMAN; DKFZp781M2392; Meconium Antigen 100.	WB, IHC-P, ICC/IF	Human
	CEA Antibody (YA917) is an unconjugated, approximately 150-200 kDa, rabbit-derived, anti-CEA (YA917) monoclonal antibody. CEA Antibody (YA917) can be used for: WB,IHC-P,ICC/IF expriments in human, background without labeling.

HY-P83612

	BST2 Antibody (YA3357) Bone marrow stromal Antigen 2; BST2; CD317; HM1.24 Antigen; NPC A 7; Tetherin	WB, IHC-P, FC	Human
	BST2 Antibody (YA3357) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3357), targeting BST2, with a predicted molecular weight of 20 kDa (observed band size: 28-40 kDa). BST2 Antibody (YA3357) can be used for WB, IHC-P, FC experiment in human background.

HY-P81184

	CD80 Antibody (YA3386) Activation B7-1 Antigen; B lymphocyte activation Antigen B7; B7; B7-1; B7-1 Antigen; BB1; CD28 Antigen ligand 1; CD28LG; CD28LG1; CD80; CD80 Antigen (CD28 Antigen ligand 1, B7-1 Antigen); CD80 Antigen; CD80 molecule; CD80_HUMAN; Costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; LAB7; T-lymphocyte activation Antigen CD80; CD80_RAT.	WB, IHC-P, FC, ICC/IF	Human, Mouse
	CD80 Antibody is an unconjugated, approximately 30 kDa, mouse-derived, anti-CD80 monoclonal antibody. CD80 Antibody can be used for: WB, IHC-P,FC ICC expriments in mouse,human, and predicted: rat background without labeling.

HY-P82282

	FRA1 Antibody (YA2027) FOSL1; FRA1; Fos-related Antigen 1; FRA-1	WB, ICC/IF	Human
	FRA1 Antibody (YA2027) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2027), targeting FRA1, with a predicted molecular weight of 29 kDa (observed band size: 39 kDa). FRA1 Antibody (YA2027) can be used for WB, ICC/IF experiment in human background.

HY-P82973

	FRA2 Antibody (YA2718) FOSL2; FRA2; Fos-related Antigen 2; FRA-2	WB, IP, FC	Human, Mouse, Rat
	FRA2 Antibody (YA2718) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2718), targeting FRA2, with a predicted molecular weight of 35 kDa (observed band size: 45 kDa). FRA2 Antibody (YA2718) can be used for WB, IP, FC experiment in human, mouse, rat background.

HY-P81096

	CD14 Antibody CD14 Antigen; CD14 molecule; Lipopolysaccharide receptor; LPSR; Monocyte Differentiation Antigen 14; Monocyte differentiation Antigen CD14; Myeloid cell specific leucine rich glycoprotein; CD14_MOUSE; Myeloid cell-specific leucine-rich glycoprotein.	WB, IHC-P, ICC/IF	Human
	CD14 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CD14 monoclonal antibody. CD14 Antibody can be used for: WB,IHC-P, ICC/IF expriments in human background without labeling.

HY-P81660

	CD7 Antibody (YA1405) CD7; T-cell Antigen CD7; GP40; T-cell leukemia Antigen; T-cell surface Antigen Leu-9; TP41; CD7	FC, ELISA	Human
	CD7 Antibody (YA1405) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1405), targeting CD7. CD7 Antibody (YA1405) can be used for FC, ELISA experiment in human background.

HY-P81148

	CD8 Antibody CD8 Antigen, alpha polypeptide (p32); CD8a; CD8a Antigen; CD8a molecule; CD8A_MOUSE; CD8A_HUMAN; Leu2; Leu2 T lymphocyte Antigen; MAL; OKT8 T cell Antigen; p32; T cell Antigen Leu2; T cell co receptor; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation Antigen T8/Leu-2; T8 T cell Antigen.	WB, IHC-P, ICC/IF	Mouse
	CD8 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CD8 polyclonal antibody. CD8 Antibody can be used for: WB, IHC-P, IHC-F, IF expriments in human, mouse, background without labeling.

HY-P83480

	HLA G Antibody (YA3225) HLA G Antigen; MHC class I Antigen G; HLA-G; HLA60; HLAG	WB	Human
	HLA G Antibody (YA3225) is a biotin-conjugated non-conjugated IgG antibody, targeting HLA G, with a predicted molecular weight of 38 kDa (observed band size: 42 kDa). HLA G Antibody (YA3225) can be used for WB experiment in human background.

HY-P83295

	MelanA Antibody (YA3040) MLANA; MART1; Melanoma Antigen recognized by T-cells 1; MART-1; Antigen LB39-AA; Antigen SK29-AA; Protein Melan-A	WB, IHC-P, ICC/IF, FC	Human
	MelanA Antibody (YA3040) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3040), targeting MelanA, with a predicted molecular weight of 13 kDa (observed band size: 20 kDa). MelanA Antibody (YA3040) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.

HY-P82520

	UAP1 Antibody (YA2265) AGX; AGX1; AntigenX; SPAG2; Sperm associated Antigen 2; uap1	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
	UAP1 Antibody (YA2265) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2265), targeting UAP1, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). UAP1 Antibody (YA2265) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.

HY-P80604

	CD63 Antibody CD63 Antigen; CD63	WB, IHC-P	Human, Mouse
	CD63 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD63. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

HY-P81067

	HBcAg Antibody (YA910) Core Antigen ; Core protein	IHC-P	Human
	HBcAg Antibody (YA910) is an unconjugated, mouse-derived, anti-HBcAg (YA910) monoclonal antibody. HBcAg Antibody (YA910) can be used for: IHC-P expriments in human background without labeling.

HY-P81315

	Anthrax Protective gen Antibody (YA1060) Protective Antigen	ELISA	Bacillusanthracis
	Anthrax Protective gen Antibody (YA1060) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1060), targeting Anthrax Protective gen. Anthrax Protective gen Antibody (YA1060) can be used for ELISA experiment in bacillusanthracis background.

HY-P81366

	CD48 Antibody (YA1111) CD48; BCM1; BLAST1; CD48 Antigen; B-lymphocyte activation marker BLAST-1; BCM1 surface Antigen; Leukocyte Antigen MEM-102; TCT.1; CD48	IHC-P	Human
	CD48 Antibody (YA1111) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1111), targeting CD48. CD48 Antibody (YA1111) can be used for IHC-P experiment in human background.

HY-P83195

	HLA A Antibody (YA2940) Aw-68; HLA class I histocompatibility Antigen; A-28 alpha chain; MHC class I Antigen A68; HLA-A; MHC class I Antigen* HLA A heavy chain	WB, IHC-P, ICC/IF, IP, FC	Human
	HLA A Antibody (YA2940) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2940), targeting HLA A, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). HLA A Antibody (YA2940) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.

HY-P80610

	CD9 Antibody CD9; MIC3; TSPAN29; GIG2; CD9 Antigen; 5H9 Antigen; Cell growth-inhibiting gene 2 protein; Leukocyte Antigen MIC3; Motility-related protein; MRP-1; Tetraspanin-29; Tspan-29; p24; CD Antigen CD9	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
	CD9 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to CD9. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

HY-P81132

	CD90/Thy-1 Antibody CD90 / Thy1; CD7; CD90 Antigen; CDw90; FLJ33325; MGC128895; T25; Theta Antigen; Thy-1; Thy 1; Thy 1 cell surface Antigen; Thy-1 membrane glycoprotein; Thy 1 membrane glycoprotein precursor; Thy 1.2; Thy-1 T-cell Antigen; Thy1 Antigen; Thy1 T cell Antigen; Thy1.1; Thy1.2; Thymus cell Antigen 1, theta; THY1_RAT; THY1_HUMAN.	WB, IHC-P, ICC/IF	Human
	CD90/Thy-1 Antibody is an unconjugated, approximately 18 kDa, rabbit-derived, anti-CD90/Thy-1 monoclonal antibody. CD90/Thy-1 Antibody can be used for: WB,IHC-P,ICC/IF expriments in human background without labeling.

HY-P83577

	MHC Class I Antibody (YA3322) Aw-68; HLA class I histocompatibility Antigen; A-28 alpha chain; MHC class I Antigen A68; HLA-A; MHC class I Antigen* HLA A heavy chain	WB, IHC-P	Human
	MHC Class I Antibody (YA3322) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3322), targeting MHC Class I, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). MHC Class I Antibody (YA3322) can be used for WB, IHC-P experiment in human background.

HY-P83634

	CD1a Antibody (YA3379) CD1A; T-cell surface glycoprotein CD1a; T-cell surface Antigen T6/Leu-6; hTa1 thymocyte Antigen; CD Antigen CD1a	WB, IHC-P	Human
	CD1a Antibody (YA3379) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3379), targeting CD1a, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). CD1a Antibody (YA3379) can be used for WB, IHC-P experiment in human background.

HY-P81369

	MAGEC2 Antibody (YA1114) CT10,MAGE-C2 Antigen,MAGE-E1 Antigen,MAGEC2,HCA587, MAGEE1	IHC-P	Human
	MAGEC2 Antibody (YA1114) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1114), targeting MAGEC2. MAGEC2 Antibody (YA1114) can be used for IHC-P experiment in human background.

HY-P83606

	CEACAM6 Antibody (YA3351) CD66c; CEACAM6; CEAL; NCA; Non specific cross reacting Antigen; Normal cross reacting Antigen	WB, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	CEACAM6 Antibody (YA3351) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3351), targeting CEACAM6, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). CEACAM6 Antibody (YA3351) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.

HY-P82631

	CD239 Antibody (YA2376) BCAM; LU; MSK19; Basal cell adhesion molecule; Auberger B Antigen; B-CAM cell surface glycoprotein; F8/G253 Antigen; Lutheran Antigen; Lutheran blood group glycoprotein; CD239	WB, IHC-P, IP, FC	Human, Mouse, Rat
	CD239 Antibody (YA2376) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2376), targeting CD239, with a predicted molecular weight of 67 kDa (observed band size: 85 kDa). CD239 Antibody (YA2376) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.

HY-P81734

	PSCA Antibody (YA1479) PSCA; Prostate stem cell Antigen	FC, ELISA	Human
	PSCA Antibody (YA1479) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1479), targeting PSCA. PSCA Antibody (YA1479) can be used for FC, ELISA experiment in human background.

HY-P83339

	HLA DR Antibody (YA3084) MLRW; HLA-DRA1; MHC class II Antigen DRA; HLA class II histocompatibility Antigen; DR alpha chain	WB, IHC-P, ICC/IF, FC	Human
	HLA DR Antibody (YA3084) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3084), targeting HLA DR, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). HLA DR Antibody (YA3084) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.

HY-P80938

	p53 Antibody TP53; P53; Cellular tumor Antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53	WB, IHC-P, IHC-F, ICC/IF, ELISA	Human, Mouse, Rat, Monkey
	p53 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to p53 tumor protein. It can be used for WB,IHC,IF, ELISA assays in the background of Human, Mouse, Rat, Monkey.

HY-P83711M

	*Armenian Hamster Anti-Mouse CD80 Antibody (PE)* T-lymphocyte activation Antigen CD80; Cd80; Activation B7-1 Antigen; B7	FC	Mouse

HY-P80609

	CD86 Antibody CD86; CD28LG2; T-lymphocyte activation Antigen CD86; Activation B7-2 Antigen; B70; BU63; CTLA-4 counter-receptor B7.2; FUN-1; CD Antigen CD86	WB, IHC-P, ICC/IF, IP, FC	Human, Rat
	CD86 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 38 kDa, targeting to CD86. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.

HY-P80591

	CD105 Antibody ENG; END; Endoglin; CD Antigen CD105	WB, IHC-P, IP	Human
	CD105 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to CD105. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

HY-P80734

	Ki67 Antibody (YA001) MKI67; Antigen KI-67	IHC-P, ICC/IF	Human, Mouse
	Ki67 Antibody (YA001) is a non-conjugated and Rat origined monoclonal antibody, targeting to Ki67. It can be used for IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.

HY-P81691

	DNAM1 Antibody (YA1436) CD226; DNAM1; CD226 Antigen; DNAX accessory molecule 1; DNAM-1; CD Antigen CD226	FC, ELISA	Human
	DNAM1 Antibody (YA1436) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1436), targeting DNAM1. DNAM1 Antibody (YA1436) can be used for FC, ELISA experiment in human background.

HY-P82667

	CD226 Antibody (YA2412) CD226; DNAM1; CD226 Antigen; DNAX accessory molecule 1; DNAM-1; CD Antigen CD226	WB	Human
	CD226 Antibody (YA2412) is a biotin-conjugated non-conjugated IgG antibody, targeting CD226, with a predicted molecular weight of 39 kDa (observed band size: 60-80 kDa). CD226 Antibody (YA2412) can be used for WB experiment in human background.

HY-P82773

	Ly6A/E Antibody (YA2518) Ly-6A.2/Ly-6E.1; Ly6a; Ly6al; Lymphocyte Antigen 6A-2/6E-1; Lymphocyte Antigen Ly 6A.2/Ly 6E.1; SCA-1; Stem cell Antigen 1; T cell activating protein; TAP	WB, IHC-P	Mouse
	Ly6A/E Antibody (YA2518) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2518), targeting Ly6A/E, with a predicted molecular weight of 14 kDa (observed band size: 18 kDa). Ly6A/E Antibody (YA2518) can be used for WB, IHC-P experiment in mouse background.

HY-P80603

	CD45 Antibody (YA800) PTPRC; CD45; Receptor-type tyrosine-protein phosphatase C; Leukocyte common Antigen; L-CA; T200; CD Antigen CD45	WB, IHC-P	Human, Mouse
	CD45 Antibody (YA800) is a non-conjugated and Mouse origined monoclonal antibody about 147 kDa, targeting to CD45. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

HY-P81098

	CD34 Antibody CD34 Antigen; CD34 molecule; Cluster designation 34; Hematopoietic progenitor cell Antigen CD34; HPCA1; CD34_HUMAN.	WB, ELISA, IHC-P, IHC-F, FC, ICC/IF	Human, Mouse
	CD34 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CD34 polyclonal antibody. CD34 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit background without labeling.

HY-P81659

	CD5 Antibody (YA1404) CD5; LEU1; T-cell surface glycoprotein CD5; Lymphocyte Antigen T1/Leu-1; CD Antigen CD5	WB, IHC-P, ICC/IF, IP	Human
	CD5 Antibody (YA1404) is a biotin-conjugated non-conjugated IgG antibody, targeting CD5, with a predicted molecular weight of 55 kDa. CD5 Antibody (YA1404) can be used for WB,IHC-P,ICC/IF,IP experiment in human background.

HY-P82515

	CD83 Antibody (YA2260) CD83; CD83 Antigen; hCD83; B-cell activation protein; Cell surface protein HB15; CD Antigen CD83	WB	Human, Mouse, Rat
	CD83 Antibody (YA2260) is a biotin-conjugated non-conjugated IgG antibody, targeting CD83, with a predicted molecular weight of 23 kDa (observed band size: 45 kDa). CD83 Antibody (YA2260) can be used for WB experiment in human, mouse, rat background.

HY-P83720

	CD5 Antibody (YA3453) CD5; LEU1; T-cell surface glycoprotein CD5; Lymphocyte Antigen T1/Leu-1; CD Antigen CD5	WB, IHC-P, FC, ELISA	Human, Mouse
	CD5 Antibody (YA3453) is a non-conjugated IgG1 antibody, targeting CD5, with a predicted molecular weight of 55 kDa. CD5 Antibody (YA3453) can be used for WB,IHC-P,FC,ELISA experiment in human，mouse background.

HY-P80595

	CD146 Antibody A32 Antigen antibody; CD 146 antibody; CD146 antibody; CD146 Antigen antibody; Cell surface glycoprotein MUC18 antibody; Cell surface glycoprotein P1H12 antibody; Gicerin antibody; Mcam antibody; Melanoma adhesion molecule antibody; Melanoma associated Antigen A32 antibody; Melanoma associated Antigen MUC18 antibody; Melanoma associated glycoprotein MUC18 antibody; Melanoma cell adhesion molecule antibody; Melanoma-associated Antigen A32 antibody; Melanoma-associated Antigen MUC18 antibody; MelCAM antibody; MUC 18 antibody; MUC18 antibody; MUC18_HUMAN antibody; S endo 1 antibody; S endo 1 endothelial associated Antigen antibody; S-endo 1 endothelial-associated Antigen antibody	WB, IHC-F, IHC-P, ICC/IF	Human, Rat
	CD146 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to CD146. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Rat.

HY-P83689

	CD147 Antibody (YA3422) HT-7; CD147; EMMPRIN; AI115436; AI325119; BSG; Basigin; 5F7; EMMPRIN; Leukocyte activation Antigen M6; OK blood group Antigen; Tumor cell-derived collagenase stimulatory factor; TCSF; CD Antigen CD147	WB, IHC-P, IHC-F, ICC/IF	Human
	CD147 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to CD147. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.

HY-P83392

	KCTD3 Antibody (YA3137) Renal carcinoma Antigen NY-REN-45	WB	Human
	KCTD3 Antibody (YA3137) is a biotin-conjugated non-conjugated IgG antibody, targeting KCTD3, with a predicted molecular weight of 89 kDa (observed band size: 89 kDa). KCTD3 Antibody (YA3137) can be used for WB experiment in human background.

HY-P81512A

	uPAR Antibody U-PAR; Monocyte activation Antigen Mo3; CD87	WB, IHC-P	Human

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-159102

PVP-037.2		Azide
PVP-037.2 is a TLR7/8 agonist. PVP-037.2 can serve as an adjuvant to enhance vaccine-induced T_H1 type immune responses, increasing the production of antigen-specific antibodies IgG1 and IgG2c .

Cat. No.	Product Name		Classification

HY-157745

m-PEG-NHS ester (MW 40000) mPEG-SC (MW 40000); mPEG-Succinimidyl ester (MW 40000)		Polymers
m-PEG-NHS ester (MW 40000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects .

HY-109506

DPPC 5 Publications Verification 129Y83		Phospholipids
DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice .

HY-153084

CD19 CAR mRNA (Mouse) 1 Publications Verification		mRNA
CD19 CAR mRNA (Mouse) will express mouse CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.

HY-153084A

CD19 CAR mRNA (Human)		mRNA
CD19 CAR mRNA (Human) will express Human CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.

HY-159751

HS101		Adjuvant
HS101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159752

HS103		Adjuvant
HS103 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159753

HS105		Adjuvant
HS105 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159754

HS201		Adjuvant
HS201 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159746

HS801		Adjuvant
HS801 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159743

M101		Adjuvant
M101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159744

M103		Adjuvant
M103 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159745

M107		Adjuvant
M107 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159747

M401		Adjuvant
M401 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159748

M402		Adjuvant
M402 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159749

M902		Adjuvant
M902 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159750

M903		Adjuvant
M903 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-156087

Cholicamideβ		Adjuvant
Cholicamideβ (GMP) is a GMP grade of Cholicamideβ. Cholicamideβ (compound 6) is a self-assembling, small molecule, cancer vaccine adjuvant. Cholicamideβ can form virus-like particles with low cytotoxicity. Cholicamideβ, upon binding to peptide antigens, enhances antigen presentation by dendritic cells and induces antigen-specific T cells. Cholicamideβ can induce apoptosis and necrosis .

HY-153233

CD19 car mRNA (Mouse)-LNP		mRNA
CD19 car mRNA (Mouse)-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .

HY-153209

ISATM51		Adjuvant
ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .

HY-153205

Aluminum hydroxide adjuvant		Adjuvant
Aluminum hydroxide adjuvant is a vaccine adjuvant. Aluminum hydroxide adjuvant induces the differentiation of macrophages into a new type of mature, specialized antigen-presenting cells in vitro .

HY-153808B

Complete Freund's adjuvant (CFA, 1 mg/ml)		Adjuvant
Complete Freund's adjuvant (CFA, 1 mg/ml) is an immunoadjuvant emulsified with antigen that can enhance an animal's immune response to an antigen. Complete Freund's adjuvant (CFA, 1 mg/ml) is also an inducer of the Th1 immune response and a ligand of TLRs. Complete Freund's adjuvant (CFA, 1 mg/ml) contains heat-killed inactive tuberculosis bacilli and consists of a paraffin oil-in-water emulsion. Complete Freund's adjuvant (CFA, 1 mg/ml) stimulates a strong and durable immune response and can be used to induce rheumatoid arthritis in rats, and more .

HY-160046

AS2 sodium		Aptamers
AS2 sodium is an ssDNA aptamer (Kd: 0.7 nM) for prostate-specific antigen (PSA). AS2 sodium does not bind non-specifically to the anti-target and has the potential to be used in diagnostic systems for prostate cancer detection .

HY-160577

DOG-IM4		Cationic Lipids
DOG-IM4 can be used to synthesize nanoparticles to deliver antigen-encoding nucleic acids. It could be used to try to target autoimmune diseases, rare blood or metabolic diseases, allergies, cancer or infectious diseases .

HY-132603A

AB-729 sodium		siRNAs
AB-729 sodium is a siRNA specifically designed to inhibit viral replication and reduces HBV antigens . AB-729 conjugates to a trimer of N-acetylgalactosamine (GalNAc) ligand that promotes uptake into hepatocytes via the asialoglycoprotein receptor (ASGR).

HY-153808

Complete Freund's adjuvant (CFA) 4 Publications Verification		Adjuvant
Complete Freund's adjuvant (CFA) is an immunoadjuvant emulsified with antigen by its discoverer Jules T. Freund to enhance an animal's immune response to an antigen. Complete Freund's adjuvant (CFA) is also an inducer of the Th1 immune response and a ligand of TLRs. Complete Freund's adjuvant (CFA) contains heat-killed inactive tuberculosis bacilli and consists of a paraffin oil-in-water emulsion. Complete Freund's adjuvant (CFA) stimulates a strong and durable immune response and can be used to induce persistent inflammatory pain models in mice, experimental autoimmune myocarditis (EAM) models, and more. Incomplete Freund's adjuvant (IFA) (HY-153808A) is another type of Freund's Adjuvant that stimulates a weaker immune response .

HY-155909

m-PEG-NHS ester (MW 3400) mPEG-SC (MW 3400); mPEG-Succinimidyl ester (MW 3400)		Polymers
m-PEG-NHS ester (MW 3400) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.

HY-155909A

m-PEG-NHS ester (MW 1000) mPEG-SC (MW 1000); mPEG-Succinimidyl ester (MW 1000)		Polymers
m-PEG-NHS ester (MW 1000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.

HY-155909B

m-PEG-NHS ester (MW 550) mPEG-SC (MW 550); mPEG-Succinimidyl ester (MW 550)		Polymers
m-PEG-NHS ester (MW 550) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.

HY-155909C

m-PEG-NHS ester (MW 350) mPEG-SC (MW 350); mPEG-Succinimidyl ester (MW 350)		Polymers
m-PEG-NHS ester (MW 350) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.

HY-W591424

m-PEG-NHS ester (MW 2000) mPEG-SC (MW 2000); mPEG-Succinimidyl ester (MW 2000)		Polymers
m-PEG-NHS ester (MW 2000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.

HY-153879

C12-TLRa		Cationic Lipids
C12-TLRa is an adjuvant lipidoid. C12-TLRa acts as a structural component of LNP to enhance mRNA delivery. C12-TLRa substitution can increase antigen-specific antibody responses and B cell responses of clinically relevant mRNA-LNP vaccines .

HY-112758

DLin-KC2-DMA 4 Publications Verification		Cationic Lipids
DLin-KC2-DMA is an ionisable cationic lipid (pKa≈6) that is virtually non-toxic to antigen presenting cells (APCs). DLin-KC2-DMA produces significant siRNA-mediated gene silencing of GAPDH, when binds to lipid nanoparticles (LNP). DLin-KC2-DMA can be used in siRNA delivery studies .

HY-153808A

Incomplete Freund's adjuvant (IFA) Montanide ISA-51		Adjuvant
Incomplete Freund's adjuvant (IFA) (Montanide ISA-51) is an immunoadjuvant emulsified with antigen by its discoverer Jules T. Freund. Incomplete Freund's adjuvant (IFA) does not contain inactivated tuberculosis bacilli and consists of petroleum jelly containing lanolin. Incomplete Freund's adjuvant (IFA) induces high antibody titers and long-lasting effector T cell responses with no long-term effects on collagen disease, tumors, or death. Complete Freund's adjuvant (CFA) (HY-153808) is another type of Freund's Adjuvant that stimulates a stronger immune response .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Antigen

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

Peptides

MCE Kits

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

Natural
Products